0001289848 12/31 2026 Q2 false 6 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares hurn:Segment utr:Rate xbrli:pure iso4217:INR 0001289848 2026-01-01 2026-06-30 0001289848 2026-07-21 0001289848 2026-06-30 0001289848 2025-12-31 0001289848 2026-04-01 2026-06-30 0001289848 2025-04-01 2025-06-30 0001289848 2025-01-01 2025-06-30 0001289848 us-gaap:CommonStockMember 2026-03-31 0001289848 us-gaap:TreasuryStockCommonMember 2026-03-31 0001289848 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001289848 us-gaap:RetainedEarningsMember 2026-03-31 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001289848 2026-03-31 0001289848 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001289848 us-gaap:TreasuryStockCommonMember 2026-04-01 2026-06-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001289848 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001289848 us-gaap:CommonStockMember 2026-06-30 0001289848 us-gaap:TreasuryStockCommonMember 2026-06-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001289848 us-gaap:RetainedEarningsMember 2026-06-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001289848 us-gaap:CommonStockMember 2025-03-31 0001289848 us-gaap:TreasuryStockCommonMember 2025-03-31 0001289848 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001289848 us-gaap:RetainedEarningsMember 2025-03-31 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001289848 2025-03-31 0001289848 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001289848 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001289848 us-gaap:CommonStockMember 2025-06-30 0001289848 us-gaap:TreasuryStockCommonMember 2025-06-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001289848 us-gaap:RetainedEarningsMember 2025-06-30 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001289848 2025-06-30 0001289848 us-gaap:CommonStockMember 2025-12-31 0001289848 us-gaap:TreasuryStockCommonMember 2025-12-31 0001289848 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001289848 us-gaap:RetainedEarningsMember 2025-12-31 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001289848 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0001289848 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-06-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-06-30 0001289848 us-gaap:RetainedEarningsMember 2026-01-01 2026-06-30 0001289848 us-gaap:CommonStockMember 2024-12-31 0001289848 us-gaap:TreasuryStockCommonMember 2024-12-31 0001289848 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001289848 us-gaap:RetainedEarningsMember 2024-12-31 0001289848 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001289848 2024-12-31 0001289848 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001289848 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-06-30 0001289848 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0001289848 hurn:RelateCareMember 2026-06-03 2026-06-03 0001289848 hurn:RelateCareMember 2026-06-03 0001289848 hurn:A2025AcquisitionsMember 2026-01-01 2026-06-30 0001289848 hurn:HealthcareMember hurn:EclipseLLCMember hurn:A2025AcquisitionsMember 2026-01-01 2026-06-30 0001289848 hurn:CommercialMember hurn:TVG_TreliantHoldingsLLCMember hurn:A2025AcquisitionsMember 2026-01-01 2026-06-30 0001289848 hurn:CommercialMember hurn:WilsonPerumalAndCompanyInc.Member hurn:A2025AcquisitionsMember 2026-01-01 2026-06-30 0001289848 hurn:A2025AcquisitionsMember hurn:EducationHealthcareMember 2026-01-01 2026-06-30 0001289848 hurn:A2025AcquisitionsMember 2026-06-30 0001289848 hurn:A2025AcquisitionsMember hurn:EclipseLLCMember 2026-01-01 2026-06-30 0001289848 hurn:EclipseLLCMember hurn:A2025AcquisitionsMember us-gaap:CustomerRelationshipsMember 2026-01-01 2026-06-30 0001289848 hurn:EclipseLLCMember hurn:A2025AcquisitionsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2026-01-01 2026-06-30 0001289848 hurn:EclipseLLCMember hurn:A2025AcquisitionsMember us-gaap:CustomerRelationshipsMember 2026-06-30 0001289848 hurn:EclipseLLCMember hurn:A2025AcquisitionsMember us-gaap:TechnologyBasedIntangibleAssetsMember 2026-06-30 0001289848 hurn:TVG_TreliantHoldingsLLCMember hurn:A2025AcquisitionsMember us-gaap:CustomerRelationshipsMember 2026-01-01 2026-06-30 0001289848 hurn:TVG_TreliantHoldingsLLCMember hurn:A2025AcquisitionsMember us-gaap:CustomerRelationshipsMember 2026-06-30 0001289848 hurn:A2025AcquisitionsMember 2025-04-01 2025-06-30 0001289848 hurn:A2025AcquisitionsMember 2025-01-01 2025-06-30 0001289848 hurn:HealthcareSegmentMember 2025-12-31 0001289848 hurn:EducationMember 2025-12-31 0001289848 hurn:CommercialMember 2025-12-31 0001289848 hurn:HealthcareSegmentMember 2026-01-01 2026-06-30 0001289848 hurn:EducationMember 2026-01-01 2026-06-30 0001289848 hurn:CommercialMember 2026-01-01 2026-06-30 0001289848 hurn:HealthcareSegmentMember 2026-06-30 0001289848 hurn:EducationMember 2026-06-30 0001289848 hurn:CommercialMember 2026-06-30 0001289848 hurn:RelateCareMember 2026-01-01 2026-06-30 0001289848 hurn:RelateCareMember 2026-06-30 0001289848 hurn:TVG_TreliantHoldingsLLCMember 2026-01-01 2026-06-30 0001289848 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2026-06-30 0001289848 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2026-06-30 0001289848 us-gaap:CustomerRelationshipsMember 2026-06-30 0001289848 us-gaap:CustomerRelationshipsMember 2025-12-31 0001289848 srt:MinimumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2026-06-30 0001289848 srt:MaximumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2026-06-30 0001289848 us-gaap:TechnologyBasedIntangibleAssetsMember 2026-06-30 0001289848 us-gaap:TechnologyBasedIntangibleAssetsMember 2025-12-31 0001289848 us-gaap:TradeNamesMember 2026-06-30 0001289848 us-gaap:TradeNamesMember 2025-12-31 0001289848 srt:MinimumMember us-gaap:CustomerContractsMember 2026-06-30 0001289848 srt:MaximumMember us-gaap:CustomerContractsMember 2026-06-30 0001289848 us-gaap:CustomerContractsMember 2026-06-30 0001289848 us-gaap:CustomerContractsMember 2025-12-31 0001289848 srt:MinimumMember us-gaap:NoncompeteAgreementsMember 2026-06-30 0001289848 srt:MaximumMember us-gaap:NoncompeteAgreementsMember 2026-06-30 0001289848 us-gaap:NoncompeteAgreementsMember 2026-06-30 0001289848 us-gaap:NoncompeteAgreementsMember 2025-12-31 0001289848 hurn:ChangeinEstimatedVariableConsiderationMember 2026-04-01 2026-06-30 0001289848 hurn:ReleaseofAllowanceMember 2026-04-01 2026-06-30 0001289848 hurn:ChangeinEstimatedVariableConsiderationMember 2025-04-01 2025-06-30 0001289848 hurn:ReleaseofAllowanceMember 2025-04-01 2025-06-30 0001289848 hurn:ChangeinEstimatedVariableConsiderationMember 2026-01-01 2026-06-30 0001289848 hurn:ReleaseofAllowanceMember 2026-01-01 2026-06-30 0001289848 hurn:ChangeinEstimatedVariableConsiderationMember 2025-01-01 2025-06-30 0001289848 hurn:ReleaseofAllowanceMember 2025-01-01 2025-06-30 0001289848 2026-07-01 2026-06-30 0001289848 2027-01-01 2026-06-30 0001289848 2028-01-01 2026-06-30 0001289848 hurn:ShareRepurchaseProgramMember 2020-11-30 0001289848 hurn:ShareRepurchaseProgramMember 2026-06-30 0001289848 hurn:ShareRepurchaseProgramMember 2026-04-01 2026-06-30 0001289848 hurn:ShareRepurchaseProgramMember 2026-01-01 2026-06-30 0001289848 hurn:ShareRepurchaseProgramMember 2025-04-01 2025-06-30 0001289848 hurn:ShareRepurchaseProgramMember 2025-01-01 2025-06-30 0001289848 hurn:ShareRepurchaseProgramMember 2025-01-01 2025-03-31 0001289848 hurn:ShareRepurchaseProgramMember 2024-12-31 0001289848 hurn:AmendedRevolverCreditFacilityMember 2025-07-30 0001289848 hurn:AmendedTermDebtCreditFacilityMember 2025-07-30 0001289848 hurn:AmendedCreditFacilityMember 2025-07-01 2025-07-31 0001289848 hurn:AmendedTermDebtCreditFacilityMember 2025-07-01 2025-07-31 0001289848 hurn:AmendedRevolverCreditFacilityMember 2026-06-30 0001289848 hurn:AmendedTermDebtCreditFacilityMember 2026-06-30 0001289848 hurn:AmendedCreditFacilityMember 2025-07-30 0001289848 hurn:AmendedCreditFacilityMember srt:MinimumMember us-gaap:SecuredOvernightFinancingRateSofrMember 2025-07-01 2025-07-31 0001289848 hurn:AmendedCreditFacilityMember srt:MaximumMember us-gaap:SecuredOvernightFinancingRateSofrMember 2025-07-01 2025-07-31 0001289848 hurn:AmendedCreditFacilityMember srt:MinimumMember us-gaap:BaseRateMember 2025-07-01 2025-07-31 0001289848 hurn:AmendedCreditFacilityMember srt:MaximumMember us-gaap:BaseRateMember 2025-07-01 2025-07-31 0001289848 hurn:AmendedCreditFacilityMember 2026-06-30 0001289848 hurn:AmendedRevolverCreditFacilityMember 2025-12-31 0001289848 hurn:AmendedTermDebtCreditFacilityMember 2025-12-31 0001289848 hurn:AmendedCreditFacilityMember 2025-12-31 0001289848 hurn:ExistingCreditFacilityMember 2025-12-31 0001289848 hurn:OfficeSpaceReductionsThatWereInitiatedInPriorPeriodsMember hurn:PreviouslyVacatedOfficeSpaceMember 2026-04-01 2026-06-30 0001289848 hurn:NonCashGainOnLeaseModificationMember hurn:PreviouslyVacatedOfficeSpaceMember 2026-04-01 2026-06-30 0001289848 us-gaap:EmployeeSeveranceMember 2026-01-01 2026-06-30 0001289848 hurn:OfficeSpaceReductionsThatWereInitiatedInPriorPeriodsMember hurn:PreviouslyVacatedOfficeSpaceMember 2026-01-01 2026-06-30 0001289848 hurn:NonCashGainOnLeaseModificationMember hurn:PreviouslyVacatedOfficeSpaceMember 2026-01-01 2026-06-30 0001289848 hurn:NonCashGainOnLeaseModificationMember hurn:PreviouslyVacatedOfficeSpaceMember 2026-01-01 2026-03-31 0001289848 hurn:OfficeSpaceReductionsThatWereInitiatedInPriorPeriodsMember hurn:PreviouslyVacatedOfficeSpaceMember 2025-01-01 2025-06-30 0001289848 hurn:OfficeSpaceReductionsThatWereInitiatedInPriorPeriodsMember hurn:OfficeSpaceReductionsMember 2025-01-01 2025-06-30 0001289848 us-gaap:EmployeeSeveranceMember 2025-12-31 0001289848 us-gaap:OtherRestructuringMember 2025-12-31 0001289848 us-gaap:OtherRestructuringMember 2026-01-01 2026-06-30 0001289848 us-gaap:EmployeeSeveranceMember 2026-06-30 0001289848 us-gaap:OtherRestructuringMember 2026-06-30 0001289848 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2026-06-30 0001289848 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2025-12-31 0001289848 us-gaap:DesignatedAsHedgingInstrumentMember 2026-01-01 2026-06-30 0001289848 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember 2026-01-01 2026-06-30 0001289848 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2026-01-01 2026-06-30 0001289848 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2026-06-30 0001289848 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeContractMember 2025-12-31 0001289848 us-gaap:NondesignatedMember hurn:UnsettledDerivativeMember us-gaap:ForeignExchangeContractMember 2026-06-30 0001289848 us-gaap:NondesignatedMember hurn:UnsettledDerivativeMember us-gaap:ForeignExchangeContractMember 2026-04-01 2026-06-30 0001289848 us-gaap:NondesignatedMember hurn:SettledDerivativeMember us-gaap:ForeignExchangeContractMember 2026-04-01 2026-06-30 0001289848 us-gaap:NondesignatedMember hurn:SettledDerivativeMember us-gaap:ForeignExchangeContractMember 2025-04-01 2025-06-30 0001289848 us-gaap:NondesignatedMember hurn:SettledDerivativeMember us-gaap:ForeignExchangeContractMember 2025-01-01 2025-06-30 0001289848 us-gaap:PrepaidExpenseAndOtherAssetsCurrent 2026-06-30 0001289848 us-gaap:PrepaidExpenseAndOtherAssetsCurrent 2025-12-31 0001289848 us-gaap:OtherAssetsNoncurrent 2026-06-30 0001289848 us-gaap:OtherAssetsNoncurrent 2025-12-31 0001289848 us-gaap:AccruedLiabilitiesCurrentAndNoncurrent 2026-06-30 0001289848 us-gaap:AccruedLiabilitiesCurrentAndNoncurrent 2025-12-31 0001289848 us-gaap:OtherLiabilitiesNoncurrent 2026-06-30 0001289848 us-gaap:OtherLiabilitiesNoncurrent 2025-12-31 0001289848 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2026-06-30 0001289848 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001289848 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member 2026-06-30 0001289848 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001289848 hurn:DeferredCompensationPlanAssetsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2026-06-30 0001289848 hurn:DeferredCompensationPlanAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001289848 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001289848 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001289848 us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001289848 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member hurn:ContingentConsiderationLiabilityMember 2026-06-30 0001289848 hurn:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001289848 us-gaap:FairValueMeasurementsRecurringMember us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001289848 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2025-12-31 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001289848 hurn:DeferredCompensationPlanAssetsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001289848 hurn:DeferredCompensationPlanAssetsMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001289848 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001289848 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001289848 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001289848 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member 2025-12-31 0001289848 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001289848 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member hurn:ContingentConsiderationLiabilityMember 2025-12-31 0001289848 hurn:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001289848 us-gaap:ConvertibleDebtSecuritiesMember hurn:ShorelightHoldingsLlcMember 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember hurn:ShorelightHoldingsLlcMember 2025-12-31 0001289848 hurn:ShorelightHoldingsLlcMember 2026-01-01 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputDiscountRateMember hurn:ShorelightHoldingsLlcMember 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputDiscountRateMember hurn:ShorelightHoldingsLlcMember 2025-12-31 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember hurn:ShorelightHoldingsLlcMember 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember hurn:ShorelightHoldingsLlcMember 2025-12-31 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember hurn:ShorelightCECLMember 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputPriceVolatilityMember hurn:ShorelightCECLMember 2025-12-31 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputDiscountRateMember srt:MinimumMember hurn:ShorelightCECLMember 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputDiscountRateMember srt:MinimumMember hurn:ShorelightCECLMember 2025-12-31 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputDiscountRateMember srt:MaximumMember hurn:ShorelightCECLMember 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputDiscountRateMember srt:MaximumMember hurn:ShorelightCECLMember 2025-12-31 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputDiscountRateMember srt:WeightedAverageMember hurn:ShorelightCECLMember 2026-06-30 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:MeasurementInputDiscountRateMember srt:WeightedAverageMember hurn:ShorelightCECLMember 2025-12-31 0001289848 2025-01-01 2025-12-31 0001289848 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2026-01-01 2026-06-30 0001289848 us-gaap:MeasurementInputDiscountRateMember srt:MinimumMember hurn:ContingentConsiderationLiabilityMember 2026-06-30 0001289848 us-gaap:MeasurementInputDiscountRateMember srt:MaximumMember hurn:ContingentConsiderationLiabilityMember 2026-06-30 0001289848 us-gaap:MeasurementInputDiscountRateMember srt:WeightedAverageMember hurn:ContingentConsiderationLiabilityMember 2026-06-30 0001289848 us-gaap:MeasurementInputDiscountRateMember srt:MinimumMember hurn:ContingentConsiderationLiabilityMember 2025-12-31 0001289848 us-gaap:MeasurementInputDiscountRateMember srt:MaximumMember hurn:ContingentConsiderationLiabilityMember 2025-12-31 0001289848 us-gaap:MeasurementInputDiscountRateMember srt:WeightedAverageMember hurn:ContingentConsiderationLiabilityMember 2025-12-31 0001289848 hurn:ContingentConsiderationLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2026-01-01 2026-06-30 0001289848 us-gaap:OtherLiabilitiesCurrent 2026-06-30 0001289848 us-gaap:OtherLiabilitiesNoncurrent 2026-06-30 0001289848 us-gaap:CommonStockMember hurn:MedicallyHomeGroupInc.Member 2026-06-30 0001289848 us-gaap:CommonStockMember hurn:MedicallyHomeGroupInc.Member 2026-04-01 2026-06-30 0001289848 us-gaap:PreferredStockMember hurn:MedicallyHomeGroupInc.Member 2025-04-01 2025-06-30 0001289848 us-gaap:PreferredStockMember hurn:MedicallyHomeGroupInc.Member 2025-07-01 2025-09-30 0001289848 us-gaap:PreferredStockMember hurn:MedicallyHomeGroupInc.Member 2025-12-31 0001289848 us-gaap:InterestRateSwapMember 2026-04-01 2026-06-30 0001289848 us-gaap:InterestRateSwapMember 2025-04-01 2025-06-30 0001289848 us-gaap:ForeignExchangeContractMember 2026-04-01 2026-06-30 0001289848 us-gaap:ForeignExchangeContractMember 2025-04-01 2025-06-30 0001289848 us-gaap:InterestRateSwapMember 2026-01-01 2026-06-30 0001289848 us-gaap:InterestRateSwapMember 2025-01-01 2025-06-30 0001289848 us-gaap:ForeignExchangeContractMember 2026-01-01 2026-06-30 0001289848 us-gaap:ForeignExchangeContractMember 2025-01-01 2025-06-30 0001289848 us-gaap:AccumulatedTranslationAdjustmentMember 2025-12-31 0001289848 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2025-12-31 0001289848 us-gaap:InterestRateSwapMember 2025-12-31 0001289848 us-gaap:ForeignExchangeContractMember 2025-12-31 0001289848 us-gaap:AccumulatedTranslationAdjustmentMember 2026-06-30 0001289848 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2026-06-30 0001289848 us-gaap:InterestRateSwapMember 2026-06-30 0001289848 us-gaap:ForeignExchangeContractMember 2026-06-30 0001289848 hurn:A20252026AcquisitionMember 2026-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:HealthcareMember 2026-04-01 2026-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:HealthcareMember 2025-04-01 2025-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:HealthcareMember 2026-01-01 2026-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:HealthcareMember 2025-01-01 2025-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:EducationMember 2026-04-01 2026-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:EducationMember 2025-04-01 2025-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:EducationMember 2026-01-01 2026-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:EducationMember 2025-01-01 2025-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:CommercialMember 2026-04-01 2026-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:CommercialMember 2025-04-01 2025-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:CommercialMember 2026-01-01 2026-06-30 0001289848 us-gaap:OperatingSegmentsMember hurn:CommercialMember 2025-01-01 2025-06-30 0001289848 us-gaap:OperatingSegmentsMember 2026-04-01 2026-06-30 0001289848 us-gaap:OperatingSegmentsMember 2025-04-01 2025-06-30 0001289848 us-gaap:OperatingSegmentsMember 2026-01-01 2026-06-30 0001289848 us-gaap:OperatingSegmentsMember 2025-01-01 2025-06-30 0001289848 us-gaap:MaterialReconcilingItemsMember 2026-04-01 2026-06-30 0001289848 us-gaap:MaterialReconcilingItemsMember 2025-04-01 2025-06-30 0001289848 us-gaap:MaterialReconcilingItemsMember 2026-01-01 2026-06-30 0001289848 us-gaap:MaterialReconcilingItemsMember 2025-01-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:HealthcareMember 2026-04-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:HealthcareMember 2025-04-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:HealthcareMember 2026-01-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:HealthcareMember 2025-01-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:HealthcareMember 2026-04-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:HealthcareMember 2025-04-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:HealthcareMember 2026-01-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:HealthcareMember 2025-01-01 2025-06-30 0001289848 hurn:HealthcareMember 2026-04-01 2026-06-30 0001289848 hurn:HealthcareMember 2025-04-01 2025-06-30 0001289848 hurn:HealthcareMember 2026-01-01 2026-06-30 0001289848 hurn:HealthcareMember 2025-01-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:EducationMember 2026-04-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:EducationMember 2025-04-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:EducationMember 2026-01-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:EducationMember 2025-01-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:EducationMember 2026-04-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:EducationMember 2025-04-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:EducationMember 2026-01-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:EducationMember 2025-01-01 2025-06-30 0001289848 hurn:EducationMember 2026-04-01 2026-06-30 0001289848 hurn:EducationMember 2025-04-01 2025-06-30 0001289848 hurn:EducationMember 2025-01-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:CommercialMember 2026-04-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:CommercialMember 2025-04-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:CommercialMember 2026-01-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:CommercialMember 2025-01-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:CommercialMember 2026-04-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:CommercialMember 2025-04-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:CommercialMember 2026-01-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:CommercialMember 2025-01-01 2025-06-30 0001289848 hurn:CommercialMember 2026-04-01 2026-06-30 0001289848 hurn:CommercialMember 2025-04-01 2025-06-30 0001289848 hurn:CommercialMember 2025-01-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember 2026-04-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember 2025-04-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember 2026-01-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember 2025-01-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember 2026-04-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember 2025-04-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember 2026-01-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember 2025-01-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:HealthcareMember 2026-04-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:HealthcareMember 2025-04-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:HealthcareMember 2026-01-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:HealthcareMember 2025-01-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:HealthcareMember 2026-04-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:HealthcareMember 2025-04-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:HealthcareMember 2026-01-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:HealthcareMember 2025-01-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:EducationMember 2026-04-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:EducationMember 2025-04-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:EducationMember 2026-01-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:EducationMember 2025-01-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:EducationMember 2026-04-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:EducationMember 2025-04-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:EducationMember 2026-01-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:EducationMember 2025-01-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:CommercialMember 2026-04-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:CommercialMember 2025-04-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:CommercialMember 2026-01-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember hurn:CommercialMember 2025-01-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:CommercialMember 2026-04-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:CommercialMember 2025-04-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember hurn:CommercialMember 2026-01-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember hurn:CommercialMember 2025-01-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember 2026-04-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember 2025-04-01 2025-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember 2026-01-01 2026-06-30 0001289848 hurn:ConsultingAndManagedServicesCapabilityMember 2025-01-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember 2026-04-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember 2025-04-01 2025-06-30 0001289848 hurn:DigitalCapabilityMember 2026-01-01 2026-06-30 0001289848 hurn:DigitalCapabilityMember 2025-01-01 2025-06-30
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2026
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-50976

HURON CONSULTING GROUP INC.
(Exact name of registrant as specified in its charter)

Delaware |  | 01-0666114
(State or other jurisdiction of incorporation or organization) |  | (IRS Employer Identification Number)

550 West Van Buren Street
Chicago, Illinois
60607
(Address of principal executive offices)
(Zip Code)
(312) 583-8700
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, par value $0.01 per share | HURN | Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer | ☒ | Accelerated Filer | ☐ | Non-accelerated Filer | ☐ | Smaller Reporting Company | ☐ | Emerging Growth Company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of July 21, 2026, 15,910,072 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.

Table of Contents

Huron Consulting Group Inc.

HURON CONSULTING GROUP INC.
INDEX

|  | Page
Part I – Financial Information |
Item 1. | Consolidated Financial Statements (Unaudited) |
| Consolidated Balance Sheets | 1
| Consolidated Statements of Operations and Other Comprehensive Income | 2
| Consolidated Statements of Stockholders’ Equity | 3
| Consolidated Statements of Cash Flows | 4
| Notes to Consolidated Financial Statements | 5
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 24
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 45
Item 4. | Controls and Procedures | 46
Part II – Other Information |
Item 1. | Legal Proceedings | 46
Item 1A. | Risk Factors | 46
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 46
Item 3. | Defaults Upon Senior Securities | 47
Item 4. | Mine Safety Disclosures | 47
Item 5. | Other Information | 47
Item 6. | Exhibits | 48
Signature | 49

Table of Contents
PART I - FINANCIAL INFORMATION
ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS
HURON CONSULTING GROUP INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)

| June 30, 2026 |  | December 31, 2025
Assets |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 31,228 |  |  | $ | 24,508 |
Receivables from clients, net of allowances of $10,457 and $10,519, respectively | 203,815 |  |  | 186,506 |
Unbilled services, net of allowances of $3,090 and $3,384, respectively | 238,057 |  |  | 195,464 |
Income tax receivable | 15,560 |  |  | 8,430 |
Prepaid expenses and other current assets | 41,118 |  |  | 33,676 |
Total current assets | 529,778 |  |  | 448,584 |
Property and equipment, net | 27,691 |  |  | 23,472 |
Deferred income taxes, net | 3,564 |  |  | 3,563 |
Long-term investments, net of allowances of $9,315 and $10,382, respectively | 33,931 |  |  | 36,433 |
Operating lease right-of-use assets | 20,878 |  |  | 20,027 |
Other non-current assets | 142,797 |  |  | 134,781 |
Intangible assets, net | 81,182 |  |  | 72,927 |
Goodwill | 804,939 |  |  | 786,896 |
Total assets | $ | 1,644,760 |  |  | $ | 1,526,683 |
Liabilities and stockholders’ equity |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 16,802 |  |  | $ | 12,354 |
Accrued expenses and other current liabilities | 59,416 |  |  | 38,117 |
Accrued payroll and related benefits | 173,027 |  |  | 266,950 |
Current maturities of long-term debt | 20,000 |  |  | 20,000 |
Current maturities of operating lease liabilities | 9,797 |  |  | 14,304 |
Deferred revenues | 30,885 |  |  | 31,708 |
Total current liabilities | 309,927 |  |  | 383,433 |
Non-current liabilities: |  |  |
Deferred compensation and other liabilities | 73,238 |  |  | 63,316 |
Long-term debt, net of current portion | 812,812 |  |  | 489,665 |
Operating lease liabilities, net of current portion | 21,928 |  |  | 24,371 |
Deferred income taxes, net | 42,095 |  |  | 37,269 |
Total non-current liabilities | 950,073 |  |  | 614,621 |
Commitments and contingencies |  |  |
Stockholders’ equity |  |  |
Common stock; $0.01 par value; 500,000,000 shares authorized; 19,373,897 and 20,465,234 shares issued, respectively | 194 |  |  | 205 |
Treasury stock, at cost, 3,407,005 and 3,269,301 shares, respectively | (210,434) |  |  | (189,989) |
Additional paid-in capital | 3,928 |  |  | 87,885 |
Retained earnings | 599,378 |  |  | 636,693 |
Accumulated other comprehensive loss | (8,306) |  |  | (6,165) |
Total stockholders’ equity | 384,760 |  |  | 528,629 |
Total liabilities and stockholders’ equity | $ | 1,644,760 |  |  | $ | 1,526,683 |

The accompanying notes are an integral part of the consolidated financial statements.
1

Table of Contents
HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)
(In thousands, except per share amounts)
(Unaudited)

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Revenues: |  |  |  |  |  |  |
Revenues before reimbursable expenses | $ | 465,636 |  |  | $ | 402,505 |  |  | $ | 909,348 |  |  | $ | 798,195 |
Reimbursable expenses | 9,406 |  |  | 9,250 |  |  | 17,461 |  |  | 17,701 |
Total revenues | 475,042 |  |  | 411,755 |  |  | 926,809 |  |  | 815,896 |
Operating expenses: |  |  |  |  |  |  |
Direct costs (exclusive of depreciation and amortization included below) | 311,187 |  |  | 269,028 |  |  | 619,381 |  |  | 547,071 |
Reimbursable expenses | 9,406 |  |  | 9,250 |  |  | 17,461 |  |  | 17,695 |
Selling, general and administrative expenses | 89,793 |  |  | 80,217 |  |  | 174,504 |  |  | 156,851 |
Other losses (gains) | 3,850 |  |  | (71) |  |  | 7,690 |  |  | (71) |
Restructuring charges | 410 |  |  | 560 |  |  | 1,073 |  |  | 1,898 |
Depreciation and amortization | 10,148 |  |  | 7,117 |  |  | 19,869 |  |  | 14,066 |
Total operating expenses | 424,794 |  |  | 366,101 |  |  | 839,978 |  |  | 737,510 |
Operating income | 50,248 |  |  | 45,654 |  |  | 86,831 |  |  | 78,386 |
Other income (expense), net: |  |  |  |  |  |  |
Interest expense, net of interest income | (11,939) |  |  | (9,281) |  |  | (20,830) |  |  | (14,928) |
Other income (expense), net | 4,599 |  |  | (8,665) |  |  | 3,973 |  |  | (14,298) |
Total other expense, net | (7,340) |  |  | (17,946) |  |  | (16,857) |  |  | (29,226) |
Income before taxes | 42,908 |  |  | 27,708 |  |  | 69,974 |  |  | 49,160 |
Income tax expense | 11,674 |  |  | 8,278 |  |  | 15,493 |  |  | 5,194 |
Net income | $ | 31,234 |  |  | $ | 19,430 |  |  | $ | 54,481 |  |  | $ | 43,966 |
Earnings per share: |  |  |  |  |  |  |
Net income per basic share | $ | 1.93 |  |  | $ | 1.12 |  |  | $ | 3.28 |  |  | $ | 2.50 |
Net income per diluted share | $ | 1.91 |  |  | $ | 1.09 |  |  | $ | 3.22 |  |  | $ | 2.42 |
Weighted average shares used in calculating earnings per share: |  |  |  |  |  |  |
Basic | 16,208 |  |  | 17,320 |  |  | 16,594 |  |  | 17,569 |
Diluted | 16,387 |  |  | 17,772 |  |  | 16,902 |  |  | 18,137 |
Comprehensive income (loss): |  |  |  |  |  |  |
Net income | $ | 31,234 |  |  | $ | 19,430 |  |  | $ | 54,481 |  |  | $ | 43,966 |
Foreign currency translation adjustments, net of tax | (1,807) |  |  | 2,749 |  |  | (3,738) |  |  | 3,284 |
Unrealized loss on investment, net of tax | (1,330) |  |  | (5,249) |  |  | (1,330) |  |  | (15,766) |
Unrealized gain (loss) on cash flow hedging instruments, net of tax | 1,897 |  |  | (2,114) |  |  | 2,927 |  |  | (4,347) |
Other comprehensive loss | (1,240) |  |  | (4,614) |  |  | (2,141) |  |  | (16,829) |
Comprehensive income | $ | 29,994 |  |  | $ | 14,816 |  |  | $ | 52,340 |  |  | $ | 27,137 |

The accompanying notes are an integral part of the consolidated financial statements.
2

Table of Contents
HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In thousands, except share amounts)
(Unaudited)

| Three Months Ended June 30,
| Common Stock |  | Treasury Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Stockholders’ Equity
| Shares |  | Amount |  | Shares |  | Amount |  |  |  |
Balance at March 31, 2026 | 19,769,672 |  |  | $ | 198 |  |  | (3,409,635) |  |  | $ | (210,294) |  |  | $ | 6,322 |  |  | $ | 608,280 |  |  | $ | (7,066) |  |  | $ | 397,440 |
Comprehensive income (loss) |  |  |  |  |  |  |  |  |  |  | 31,234 |  |  | (1,240) |  |  | 29,994 |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock awards, net of cancellations | 13,258 |  |  | — |  |  | 3,697 |  |  | 142 |  |  | (142) |  |  |  |  |  |  | — |
Exercise of stock options | 646 |  |  | — |  |  |  |  |  |  | 53 |  |  |  |  |  |  | 53 |
Share-based compensation |  |  |  |  |  |  |  |  | 10,629 |  |  |  |  |  |  | 10,629 |
Shares redeemed for employee tax withholdings |  |  |  |  | (2,289) |  |  | (282) |  |  |  |  |  |  |  |  | (282) |
Share repurchases | (438,456) |  |  | (4) |  |  |  |  |  |  | (12,934) |  |  | (40,136) |  |  |  |  | (53,074) |
Balance at June 30, 2026 | 19,345,120 |  |  | $ | 194 |  |  | (3,408,227) |  |  | $ | (210,434) |  |  | $ | 3,928 |  |  | $ | 599,378 |  |  | $ | (8,306) |  |  | $ | 384,760 |
Balance at March 31, 2025 | 20,844,871 |  |  | $ | 208 |  |  | (3,274,184) |  |  | $ | (189,279) |  |  | $ | 127,495 |  |  | $ | 556,189 |  |  | $ | (329) |  |  | $ | 494,284 |
Comprehensive income (loss) |  |  |  |  |  |  |  |  |  |  | 19,430 |  |  | (4,614) |  |  | 14,816 |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock awards, net of cancellations | 5,835 |  |  | — |  |  | 4,604 |  |  | 217 |  |  | (217) |  |  |  |  |  |  | — |
Exercise of stock options | 985 |  |  | — |  |  |  |  |  |  | 64 |  |  |  |  |  |  | 64 |
Purchase of business | 147,221 |  |  | 1 |  |  |  |  |  |  | 18,552 |  |  |  |  |  |  | 18,553 |
Share-based compensation |  |  |  |  |  |  |  |  | 8,601 |  |  |  |  |  |  | 8,601 |
Shares redeemed for employee tax withholdings |  |  |  |  | (2,377) |  |  | (326) |  |  |  |  |  |  |  |  | (326) |
Share repurchases | (429,669) |  |  | (4) |  |  |  |  |  |  | (60,993) |  |  |  |  |  |  | (60,997) |
Balance at June 30, 2025 | 20,569,243 |  |  | $ | 205 |  |  | (3,271,957) |  |  | $ | (189,388) |  |  | $ | 93,502 |  |  | $ | 575,619 |  |  | $ | (4,943) |  |  | $ | 474,995 |

| Six Months Ended June 30,
| Common Stock |  | Treasury Stock |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income |  | Stockholders’ Equity
| Shares |  | Amount |  | Shares |  | Amount |  |  |  |
Balance at December 31, 2025 | 20,460,526 |  |  | $ | 205 |  |  | (3,271,442) |  |  | $ | (189,989) |  |  | $ | 87,885 |  |  | $ | 636,693 |  |  | $ | (6,165) |  |  | $ | 528,629 |
Comprehensive income (loss) |  |  |  |  |  |  |  |  |  |  | 54,481 |  |  | (2,141) |  |  | 52,340 |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock awards, net of cancellations | 428,225 |  |  | 4 |  |  | 8,479 |  |  | 367 |  |  | (371) |  |  |  |  |  |  | — |
Exercise of stock options | 9,631 |  |  | — |  |  |  |  |  |  | 761 |  |  |  |  |  |  | 761 |
Share-based compensation |  |  |  |  |  |  |  |  | 32,444 |  |  |  |  |  |  | 32,444 |
Shares redeemed for employee tax withholdings |  |  |  |  | (145,264) |  |  | (20,812) |  |  |  |  |  |  |  |  | (20,812) |
Share repurchases | (1,553,262) |  |  | (15) |  |  |  |  |  |  | (116,791) |  |  | (91,796) |  |  |  |  | (208,602) |
Balance at June 30, 2026 | 19,345,120 |  |  | $ | 194 |  |  | (3,408,227) |  |  | $ | (210,434) |  |  | $ | 3,928 |  |  | $ | 599,378 |  |  | $ | (8,306) |  |  | $ | 384,760 |
Balance at December 31, 2024 | 20,762,327 |  |  | $ | 208 |  |  | (3,117,675) |  |  | $ | (160,093) |  |  | $ | 177,673 |  |  | $ | 531,653 |  |  | $ | 11,886 |  |  | $ | 561,327 |
Comprehensive income (loss) |  |  |  |  |  |  |  |  |  |  | 43,966 |  |  | (16,829) |  |  | 27,137 |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock awards, net of cancellations | 538,410 |  |  | 5 |  |  | 60,835 |  |  | 3,212 |  |  | (3,217) |  |  |  |  |  |  | — |
Exercise of stock options | 44,187 |  |  | — |  |  |  |  |  |  | 2,591 |  |  |  |  |  |  | 2,591 |
Purchases of businesses | 162,599 |  |  | 1 |  |  |  |  |  |  | 20,896 |  |  |  |  |  |  | 20,897 |
Share-based compensation |  |  |  |  |  |  |  |  | 29,415 |  |  |  |  |  |  | 29,415 |
Shares redeemed for employee tax withholdings |  |  |  |  | (215,117) |  |  | (32,507) |  |  |  |  |  |  |  |  | (32,507) |
Share repurchases | (938,280) |  |  | (9) |  |  |  |  |  |  | (133,856) |  |  |  |  |  |  | (133,865) |
Balance at June 30, 2025 | 20,569,243 |  |  | $ | 205 |  |  | (3,271,957) |  |  | $ | (189,388) |  |  | $ | 93,502 |  |  | $ | 575,619 |  |  | $ | (4,943) |  |  | $ | 474,995 |

The accompanying notes are an integral part of the consolidated financial statements.
3

Table of Contents
HURON CONSULTING GROUP INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

| Six Months Ended June 30,
| 2026 |  | 2025
Cash flows from operating activities: |  |  |
Net income | $ | 54,481 |  |  | $ | 43,966 |
Adjustments to reconcile net income to cash flows from operating activities: |  |  |
Depreciation and amortization | 19,869 |  |  | 14,066 |
Non-cash lease expense | 3,281 |  |  | 2,855 |
Lease-related impairment charges | — |  |  | 738 |
Gain on lease modification | (4,063) |  |  | — |
Share-based compensation | 28,663 |  |  | 25,757 |
Amortization of debt discount and issuance costs | 577 |  |  | 571 |
Allowances for doubtful accounts | 100 |  |  | 396 |
Deferred income taxes | 1,592 |  |  | 399 |
Gain on sale of property and equipment | (486) |  |  | — |
Gain on sale of business | (303) |  |  | — |
Change in fair value of contingent consideration liabilities | 7,690 |  |  | (71) |
Change in fair value of equity investment | 2,239 |  |  | 5,014 |
Change in credit allowance on convertible debt investment | (1,067) |  |  | 11,125 |
Changes in operating assets and liabilities, net of acquisitions: |  |  |
(Increase) decrease in receivables from clients, net | (11,139) |  |  | 5,494 |
(Increase) decrease in unbilled services, net | (38,853) |  |  | (26,945) |
(Increase) decrease in current income tax receivable / payable, net | (6,849) |  |  | (17,161) |
(Increase) decrease in other assets | (9,934) |  |  | (6,051) |
Increase (decrease) in accounts payable and other liabilities | 2,138 |  |  | 4,063 |
Increase (decrease) in accrued payroll and related benefits | (88,680) |  |  | (91,280) |
Increase (decrease) in deferred revenues | (958) |  |  | 284 |
Net cash used in operating activities | (41,702) |  |  | (26,780) |
Cash flows from investing activities: |  |  |
Purchases of property and equipment | (10,925) |  |  | (3,892) |
Investments in life insurance policies | — |  |  | (2,312) |
Purchases of businesses, net of cash acquired | (27,790) |  |  | (53,111) |
Capitalization of internally developed software costs | (10,065) |  |  | (10,919) |
Origination of note receivable | (2,000) |  |  | — |
Proceeds from note receivable | 2,250 |  |  | 154 |
Proceeds from sale of property and equipment | 500 |  |  | — |
Proceeds from divestiture of business | 300 |  |  | — |
Net cash used in investing activities | (47,730) |  |  | (70,080) |
Cash flows from financing activities: |  |  |
Proceeds from exercises of stock options | 761 |  |  | 2,591 |
Shares redeemed for employee tax withholdings | (20,812) |  |  | (32,507) |
Share repurchases | (206,652) |  |  | (134,369) |
Proceeds from bank borrowings | 579,000 |  |  | 552,000 |
Repayments of bank borrowings | (256,000) |  |  | (251,875) |
Deferred payments for business acquisitions | — |  |  | (36) |
Net cash provided by financing activities | 96,297 |  |  | 135,804 |
Effect of exchange rate changes on cash | (145) |  |  | 156 |
Net increase in cash and cash equivalents | 6,720 |  |  | 39,100 |
Cash and cash equivalents at beginning of the period | 24,508 |  |  | 21,911 |
Cash and cash equivalents at end of the period | $ | 31,228 |  |  | $ | 61,011 |
Supplemental disclosure of cash flow information: |  |  |
Non-cash investing and financing activities: |  |  |
Property and equipment expenditures and capitalized software included in current liabilities | $ | 3,204 |  |  | $ | 3,054 |
Operating lease right-of-use assets obtained in exchange for operating lease liabilities | $ | 4,868 |  |  | $ | 1,435 |
Common stock issued related to purchases of businesses | $ | — |  |  | $ | 20,897 |
Deferred payment accrued related to purchase of business | $ | 8,728 |  |  | $ | — |
Contingent consideration accrued related to purchases of businesses | $ | 3,423 |  |  | $ | 15,400 |
Share repurchases included in current liabilities | $ | 927 |  |  | $ | — |
Excise tax on net share repurchases included in non-current liabilities | $ | 1,639 |  |  | $ | 664 |

The accompanying notes are an integral part of the consolidated financial statements.
4

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
1. Description of Business
Huron is a global professional services firm that collaborates with organizations to help solve their most complex challenges and achieve their most ambitious goals. Working across the private and public sectors, we partner closely with clients to improve performance, accelerate transformation, and unlock new opportunities for growth.
Our clients choose us because of our deep industry and technical expertise and proven track record of turning sound strategies into action. By combining practical experience, innovative thinking, and advanced analytics and technology, Huron helps organizations translate today’s ideas into tangible results and long-term value.
We provide our services and products and manage our business under three operating segments - Healthcare, Education, and Commercial - which aligns our business by industry. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services, industrials and manufacturing, energy and utilities, and the public sector. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital, which are methods by which we deliver our services and products.
See Note 15 “Segment Information” for a discussion of our three segments.
2. Basis of Presentation and Significant Accounting Policies
The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three and six months ended June 30, 2026 and 2025. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025 and our Quarterly Report on Form 10-Q for the period ended March 31, 2026. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.
3. New Accounting Pronouncements
Recently Adopted
On July 30, 2025, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets For Private Companies and Certain Not-For-Profit Entities (PCC), which provides a practical expedient for public business entities to simplify the measurement of credit losses for certain receivables and contract assets in which entities may elect to assume that the economic conditions at the time of a sale are reflective of future economic conditions, such that an entity does not need to consider future economic changes in its determination of its allowance for credit losses. We adopted ASU 2025-05 as of January 1, 2026 on a prospective basis. Upon adoption, we elected the practical expedient for current accounts receivable and current contract assets, and no other changes were made to our credit loss estimation methodologies. The adoption did not have an impact on our consolidated financial statements.
Not Yet Adopted
On November 4, 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which is intended to enhance transparency of the nature and function of expenses, primarily through additional disclosures of certain cost and expenses. ASU 2024-03 will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2027 and for interim reporting periods beginning in fiscal year 2028, with early adoption permitted, and is required to be applied prospectively with the option of retrospective application. We expect the adoption of this ASU will have no impact on our financial position or our results of operations, but will result in additional disclosures.
On September 18, 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which amends the guidance in ASC 350-40, Intangibles-Goodwill and Other-Internal-Use Software. The amendments modernize the recognition and disclosure framework for internal-use software costs, removing
5

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
the previous “development stage” model and introducing a more judgment-based approach. ASU 2025-06 will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2028, with early adoption permitted, and may be applied prospectively, retrospectively, or via a modified prospective transition method. We are currently evaluating the impact this guidance will have on our consolidated financial statements.
On November 25, 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements, which includes amendments to more closely align hedge accounting with the economics of an entity’s risk management activities. ASU 2025-09 will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2028, with early adoption permitted. We are currently evaluating the impact this guidance will have on our consolidated financial statements.
On December 8, 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. ASU 2025-11 provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 will be effective for our annual reporting periods beginning with the fiscal year ending December 31, 2028, including interim periods within those fiscal years, with early adoption permitted. We are currently evaluating the impact this guidance will have on our consolidated financial statements.
4. Acquisitions
2026 Acquisition
On June 3, 2026, we acquired 100% of the ownership interests of Akusus Holdings Limited, the parent company of RelateCare (“RelateCare”). RelateCare is a provider of AI-enabled clinical and patient access solutions. The results of operations of the acquired business are included within our consolidated financial statements and results of operations of our Healthcare segment as of the acquisition date.
The acquisition was accounted for using the acquisition method of accounting. Contract assets and contract liabilities acquired are recorded at the value calculated under Topic 606: Revenue from Contracts with Customers as if we had entered into the original contract at the same date and on the same terms as the acquired company. The acquisition date values of assets acquired and liabilities assumed in the acquisition are considered preliminary and are based on the information that was available as of the date of the acquisition. We believe that the information provides a reasonable basis for estimating the preliminary values of assets acquired and liabilities assumed but certain items, such as the valuations of the intangible assets and deferred taxes and purchase price adjustments, among other items, may be subject to change as additional information is received. Thus, the provisional measurements of assets acquired, including goodwill, and liabilities assumed related to the acquisition are subject to change. We expect to finalize the valuations as soon as practicable, but not later than one year from the acquisition date.
The revenues generated by this acquisition are not significant to our consolidated financial statements for the three and six months ended June 30, 2026. We determined that it is impractical to determine the amount of earnings generated by the acquisition due to the integration of operations after the acquisition date. Refer to Note 5 “Goodwill and Intangible Assets” for additional information on the goodwill and intangibles acquired and Note 11 “Fair Value of Financial Instruments” and Note 14 “Commitments, Contingencies and Guarantees” for additional information on our contingent consideration liabilities.
2025 Acquisitions
During 2025, we completed the following six acquisitions: Advancement Resources in March 2025, Halpin Partnership Limited (“Halpin”) in March 2025, Eclipse Insights LLC (“Eclipse Insights”) in June 2025, TVG-Treliant Holdings, LLC (“Treliant”) in July 2025, Wilson Perumal and Company, Inc. (“WP&C”) in September 2025, and AXIOM Systems Consulting Services, Inc. (“AXIOM”) in November 2025.
We finalized the measurements of assets acquired and liabilities assumed related to the Advancement Resources, Halpin, Eclipse Insights, WP&C and AXIOM acquisitions during 2025. In the first quarter of 2026, we finalized the measurements of assets acquired and liabilities assumed related to the Treliant acquisition.
The aggregate fair value of consideration transferred for all acquisitions completed in 2025 was $159.7 million, which consisted of $110.2 million in cash (inclusive of net working capital and other proceeds adjustments), $29.2 million in Huron common stock, and $20.3 million in the acquisition date fair value of contingent consideration liabilities.
6

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
We recorded goodwill related to our 2025 acquisitions of $108.1 million, of which $53.8 million related to the acquisition of Eclipse Insights within our Healthcare segment; $27.4 million related to the acquisition of Treliant within our Commercial segment; $16.5 million related to the acquisition of WP&C within our Commercial segment; and $10.4 million related to the remaining acquisitions completed in 2025. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed, and largely reflects the expanded market opportunities expected from combining the service offerings of Huron and the businesses acquired, as well as the assembled workforces of businesses acquired. Of the $108.1 million of goodwill recorded related to our 2025 acquisitions, $98.7 million is expected to be tax deductible.
Additionally, we acquired intangible assets related to our 2025 acquisitions of $58.1 million. Of the $58.1 million of intangible assets acquired, $27.6 million relates to our acquisition of Eclipse Insights and includes $25.5 million for customer relationships and $2.1 million for technology and software. The acquired customer relationships and technology and software intangible assets have an estimated useful life of 10 years and 5 years, respectively. Also included in the $58.1 million of intangible assets acquired in 2025 is $19.1 million for the Treliant customer relationships intangible asset, which has an estimated useful life of 10 years.
For the three and six months ended June 30, 2025, we recognized total revenues of $2.1 million and $2.4 million, respectively, in the aggregate, from our acquisitions completed in 2025. We determined that it is impractical to determine the amount of earnings generated by the acquisitions, individually or in the aggregate, due to the integration of operations after the acquisition date.
5. Goodwill and Intangible Assets
Goodwill
The table below sets forth the changes in the carrying value of goodwill by reportable segment for the six months ended June 30, 2026.

| Healthcare |  | Education |  | Commercial |  | Total
Balance as of December 31, 2025: |  |  |  |  |  |  |
Goodwill | $ | 701,624 |  |  | $ | 152,431 |  |  | $ | 388,733 |  |  | $ | 1,242,788 |
Accumulated impairment losses | (190,024) |  |  | (1,417) |  |  | (264,451) |  |  | (455,892) |
Goodwill, net as of December 31, 2025 | $ | 511,600 |  |  | $ | 151,014 |  |  | $ | 124,282 |  |  | $ | 786,896 |
Goodwill recorded in connection with business acquisitions(1) | 18,341 |  |  | — |  |  | 209 |  |  | 18,550 |
Foreign currency translation | (312) |  |  | (126) |  |  | (69) |  |  | (507) |
Goodwill, net as of June 30, 2026 | $ | 529,629 |  |  | $ | 150,888 |  |  | $ | 124,422 |  |  | $ | 804,939 |

(1) The $18.3 million of goodwill recorded in connection with a business acquisition in the Healthcare segment is related to the acquisition of RelateCare. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed, and largely reflects the expanded market opportunities expected from combining the service offerings of Huron and RelateCare, as well as the assembled workforce of RelateCare. All of the $18.3 million of goodwill is expected to be nondeductible for tax purposes. The $0.2 million of goodwill recorded in connection with a business acquisition in the Commercial segment relates to the finalized measurements of assets acquired and liabilities assumed in the acquisition of Treliant. See Note 4 "Acquisitions" for additional information on our business combinations completed in 2026 and 2025.
7

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
Intangible Assets
Intangible assets as of June 30, 2026 and December 31, 2025 consisted of the following:

|  |  | As of June 30, 2026 |  | As of December 31, 2025
| Useful Life (in years) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Gross Carrying Amount |  | Accumulated Amortization
Customer relationships | 4 to 10 |  | $ | 102,217 |  |  | $ | 23,970 |  |  | $ | 86,467 |  |  | $ | 17,384 |
Technology and software | 2 to 5 |  | 12,530 |  |  | 9,861 |  |  | 17,970 |  |  | 14,591 |
Trade names | 6 |  | 6,000 |  |  | 6,000 |  |  | 6,000 |  |  | 6,000 |
Customer contracts | 2 to 4 |  | 1,484 |  |  | 1,433 |  |  | 1,489 |  |  | 1,397 |
Non-competition agreements | 2 to 5 |  | 860 |  |  | 645 |  |  | 1,070 |  |  | 697 |
Total |  |  | $ | 123,091 |  |  | $ | 41,909 |  |  | $ | 112,996 |  |  | $ | 40,069 |

In connection with our acquisition of RelateCare, we acquired a $16.4 million customer relationship intangible asset, which has an initial estimated useful life of 10 years.
During the six months ended June 30, 2026, we wrote-off $6.0 million of fully amortized intangible assets related to technology and software, customer relationships, and non-competition agreements no longer in use. We did not write-off any intangible assets during the six months ended June 30, 2025.
Identifiable intangible assets with finite lives are amortized over their estimated useful lives using either an accelerated or straight-line basis to correspond to the cash flows expected to be derived from the assets. Intangible asset amortization expense was $3.9 million and $2.3 million for the three months ended June 30, 2026 and 2025, respectively; and $7.8 million and $4.3 million for the six months ended June 30, 2026 and 2025, respectively.
The table below sets forth the estimated annual amortization expense for the intangible assets recorded as of June 30, 2026.

Year Ending December 31, |  | Estimated Amortization Expense
2026 |  | $ | 15,847 |
2027 |  | $ | 14,853 |
2028 |  | $ | 14,545 |
2029 |  | $ | 11,742 |
2030 |  | $ | 9,368 |

Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.
6. Revenues
For the three months ended June 30, 2026 and 2025, we recognized total revenues of $475.0 million and $411.8 million, respectively. Of the $475.0 million total revenues recognized in the second quarter of 2026, we recognized $4.5 million from obligations satisfied, or partially satisfied, in prior periods, of which $3.0 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $1.5 million was due to the release of allowances on receivables from clients and unbilled services. Of the $411.8 million total revenues recognized in the second quarter of 2025, we recognized $12.8 million from obligations satisfied, or partially satisfied, in prior periods, of which $11.6 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $1.2 million was due to the release of allowances on receivables from clients and unbilled services.
For the six months ended June 30, 2026 and 2025, we recognized total revenues of $926.8 million and $815.9 million, respectively. Of the $926.8 million total revenues recognized in the first six months of 2026, we recognized $16.6 million from obligations satisfied, or partially satisfied in prior periods, of which $14.7 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $1.9 million was due to the release of allowances on receivables from clients and unbilled services. Of the $815.9
8

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
million total revenues recognized in the first six months of 2025, we recognized $20.5 million from obligations satisfied, or partially satisfied in prior periods, of which $18.7 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $1.8 million was due to the release of allowances on receivables from clients and unbilled services.
As of June 30, 2026, we had $271.4 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude variable consideration which has been excluded from the total transaction price due to the constraint and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the $271.4 million of performance obligations, we expect to recognize $62.1 million as revenue in 2026, $79.2 million in 2027, and the remaining $130.1 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.
Contract Assets and Liabilities
The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.
Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset, net balance as of June 30, 2026 and December 31, 2025 was $110.2 million and $91.7 million, respectively. The $18.5 million increase primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.
Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition accounting policy. Our deferred revenues balance as of June 30, 2026 and December 31, 2025 was $30.9 million and $31.7 million, respectively. The $0.8 million decrease reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three and six months ended June 30, 2026, $5.9 million and $28.7 million of revenues recognized, respectively, were included in the deferred revenue balance as of December 31, 2025.
7. Earnings Per Share
Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, unvested restricted stock units, and outstanding common stock options, to the extent dilutive. In periods for which we report a net loss, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss per share would be anti-dilutive.
Earnings per share under the basic and diluted computations are as follows:

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Net income | $ | 31,234 |  |  | $ | 19,430 |  |  | $ | 54,481 |  |  | $ | 43,966 |
Weighted average common shares outstanding – basic | 16,208 |  |  | 17,320 |  |  | 16,594 |  |  | 17,569 |
Weighted average common stock equivalents | 179 |  |  | 452 |  |  | 308 |  |  | 568 |
Weighted average common shares outstanding – diluted | 16,387 |  |  | 17,772 |  |  | 16,902 |  |  | 18,137 |
Net income per basic share | $ | 1.93 |  |  | $ | 1.12 |  |  | $ | 3.28 |  |  | $ | 2.50 |
Net income per diluted share | $ | 1.91 |  |  | $ | 1.09 |  |  | $ | 3.22 |  |  | $ | 2.42 |

9

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above was 0.1 million shares for both the three and six months ended June 30, 2026 and was less than 0.1 million shares for both the three and six months ended June 30, 2025. These shares related to unvested restricted stock and outstanding common stock options.
Share Repurchase Program
In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. The share repurchase program has been subsequently extended and increased, most recently in the first quarter of 2026. The current authorization extends the share repurchase program through December 31, 2026 with a repurchase amount of $900 million. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements.
During the three and six months ended June 30, 2026, we repurchased and retired 438,456 and 1,553,262 shares for $53.1 million and $208.6 million, respectively, which includes a $0.5 million and $1.6 million accrual for excise taxes on the net share repurchases, respectively; and includes 10,000 shares for $0.9 million which were settled in the third quarter of 2026. Additionally, in the second quarter of 2026, we paid $0.6 million for the excise taxes accrued on the net share repurchases in 2025.
During the three and six months ended June 30, 2025, we repurchased and retired 429,669 and 938,280 shares for $61.0 million and $133.9 million, respectively, which includes a $0.6 million and $0.7 million accrual for excise taxes on the net share repurchases, respectively. Additionally, in the first quarter of 2025, we settled the repurchase of 5,103 shares for $0.6 million which were accrued as of December 31, 2024.
As of June 30, 2026, $92.0 million remained available for share repurchases under our share repurchase program.
8. Financing Arrangements
The Company has a $700 million senior secured revolving credit facility (the “Revolver”) and a $400 million senior secured term loan facility (the “Term Loan”), subject to the terms of the Fourth Amended and Restated Credit Agreement dated as of July 30, 2025 (the “Amended Credit Agreement”). Both the Revolver and the Term Loan mature on July 30, 2030. The Term Loan is subject to scheduled quarterly amortization payments of $5.0 million which began September 30, 2025 and continue through the maturity date of July 30, 2030, at which time the outstanding principal balance and all accrued interest will be due.
As of June 30, 2026, we had total borrowings outstanding under the Amended Credit Agreement of $834.0 million, consisting of $454.0 million outstanding under the Revolver and $380.0 million outstanding under the Term Loan. A summary of the scheduled maturities of those borrowings as of June 30, 2026 follows:

|  | Scheduled Maturities of Long-Term Debt
2026 |  | $ | 10,000 |
2027 |  | $ | 20,000 |
2028 |  | $ | 20,000 |
2029 |  | $ | 20,000 |
2030 |  | $ | 764,000 |

Borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, share repurchases, permitted acquisitions, and other general corporate purposes. The initial borrowings under the Amended Credit Agreement were used to reduce borrowings outstanding under a prior credit agreement.
The Amended Credit Agreement provides the option to increase the revolving credit facility or establish additional term loan facilities in an aggregate amount up to $500 million with further increases permitted to the extent the Pro Forma Consolidated Leverage Ratio (as defined in the Amended Credit Agreement) remains at or below 3.00 to 1.00 following such incremental borrowings, subject to customary conditions and the approval of any lender whose commitment would be increased. These increases result in an available principal amount of $1.6 billion under the Amended Credit Agreement, with further increases permitted.
10

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
Fees and interest on borrowings under the Amended Credit Agreement will vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, these borrowings will bear interest at one, three or six month Term SOFR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.250% per annum and 1.875% per annum, in the case of Term SOFR borrowings, or between 0.250% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.
Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including upon an Event of Default (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.
The loans and obligations under the Amended Credit Agreement are secured pursuant to a Fourth Amended and Restated Security Agreement and a Fourth Amended and Restated Pledge Agreement (the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement) entitled to vote and 100% of the stock or other equity interests in each material first-tier foreign subsidiary not entitled to vote.
The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.25 to 1.00 upon the occurrence of a Qualified Acquisition (as defined in the Amended Credit Agreement), and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.00 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At June 30, 2026, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 2.82 to 1.00 and a Consolidated Interest Coverage Ratio of 7.48 to 1.00.
A summary of the carrying amounts of our debt follows:

| June 30, 2026 |  | December 31, 2025
Revolver | $ | 454,000 |  |  | $ | 121,000 |
Term Loan | 380,000 |  |  | 390,000 |
Unamortized debt issuance costs - Term Loan(1) | (1,188) |  |  | (1,335) |
Total long-term debt | 832,812 |  |  | 509,665 |
Current maturities of long-term debt | (20,000) |  |  | (20,000) |
Long-term debt, net of current portion | $ | 812,812 |  |  | $ | 489,665 |

(1)We initially recognized a $1.5 million discount to the Term Loan for debt issuance costs related to the Amended Credit Facility. These debt issuance costs are amortized to interest expense using an effective interest rate of 5.95% over the term of the Term Loan. Unamortized debt issuance costs related to the Revolver are included as a component of other non-current assets and amortized to interest expense using the straight-line method over the term of the Revolver.
Borrowings outstanding under the Amended Credit Agreement as of both June 30, 2026 and December 31, 2025 carried a weighted average interest rate of 5.3%. Both weighted average interest rates include the effect of the interest rate swaps described in Note 10 “Derivative Instruments and Hedging Activity.”
The borrowing capacity under the Revolver is reduced by any outstanding borrowings under the Revolver and outstanding letters of credit. At June 30, 2026, we had outstanding letters of credit totaling $0.4 million, which are used as security deposits for our office facilities. As of June 30, 2026, the unused borrowing capacity under the Revolver was $245.6 million.
11

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
9. Restructuring Charges
Restructuring charges for the three and six months ended June 30, 2026 were $0.4 million and $1.1 million, respectively. The $0.4 million of restructuring charges recognized in the second quarter of 2026 included $0.7 million of rent and related expenses, net of sublease income, for our previously vacated office spaces, partially offset by a $0.2 million non-cash gain on lease modification on our office space in Hillsboro, Oregon. The $1.1 million of restructuring charges recognized in the first six months of 2026 included $3.2 million of severance-related expenses and $1.7 million of rent and related expenses, net of sublease income, for our previously vacated office spaces, largely offset by $4.0 million of non-cash gains on lease modifications. In the first quarter of 2026, we entered into the Seventh Amendment to the office lease agreement for our principal executive offices in Chicago, Illinois, which, among other items, provides for the early termination of the lease with respect to certain leased spaces previously vacated. As a result of this modification, we recognized a $3.8 million non-cash gain on lease modification. See Note 14 “Commitments, Contingencies and Guarantees” within the notes to our consolidated financial statements for additional information on the Seventh Amendment to the Chicago, Illinois office lease.
Restructuring charges for the three and six months ended June 30, 2025 were $0.6 million and $1.9 million, respectively. The $0.6 million of restructuring charges recognized in the second quarter of 2025 primarily consisted of rent and related expenses, net of sublease income, for our previously vacated office spaces. The $1.9 million of restructuring charges recognized in the first six months of 2025 primarily consisted of $1.0 million of rent and related expenses, net of sublease income, for our previously vacated office spaces and a $0.7 million non-cash lease impairment charge driven by updated sublease assumptions for a previously vacated office space.
The table below sets forth the changes in the carrying value of our restructuring charge liability by restructuring type for the six months ended June 30, 2026.

| Employee Costs |  |  |  | Other |  | Total
Balance as of December 31, 2025 | $ | 1,914 |  |  |  |  | $ | 636 |  |  | $ | 2,550 |
Additions (1) | 2,643 |  |  |  |  | 107 |  |  | 2,750 |
Payments | (4,501) |  |  |  |  | (176) |  |  | (4,677) |
Adjustments (1) | (49) |  |  |  |  | 33 |  |  | (16) |
Balance as of June 30, 2026 | $ | 7 |  |  |  |  | $ | 600 |  |  | $ | 607 |

(1) Additions and adjustments exclude non-cash items related to employee costs, such as share-based compensation expense recognized upon the modification of equity awards to accelerate vesting upon termination, and non-cash items related to vacated office spaces, such as lease impairment charges, accelerated depreciation on abandoned operating lease ROU assets and fixed assets and non-cash gains on lease modifications, all of which are recorded as restructuring charges on our consolidated statements of operations.
All of the restructuring charge liability related to employee costs as of June 30, 2026 is expected to be paid in the next 12 months. All of the other restructuring charge liability at June 30, 2026, which primarily relates to the early termination of a contract in a prior period, is expected to be paid in the next 12 months. The employee costs and other restructuring charge liabilities are included as components of accrued payroll and related benefits and accrued expenses and other current liabilities in our consolidated balance sheet, respectively.
10. Derivative Instruments and Hedging Activity
In the normal course of business, we use forward interest rate swaps to manage the interest rate risk associated with our variable-rate borrowings under our senior secured credit facility and we use foreign exchange forward contracts to manage the foreign currency exchange rate risk associated with our operations in India and Canada. We do not use derivative instruments for trading or other speculative purposes.
Cash Flow Hedges
We have designated our interest rate swaps and Indian Rupee forward contracts as cash flow hedges. Therefore, changes in the fair value of these derivative instruments are recorded to other comprehensive income to the extent effective and reclassified to earnings upon settlement. Below is additional information on the derivative instruments designated as cash flow hedges in effect during the periods presented. From time to time, we may enter into additional forward interest rate swaps or Indian Rupee forward contracts to further hedge against our interest rate and foreign currency exchange rate risk.
12

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
Interest Rate Swaps: We are party to forward interest rate swap agreements with aggregate notional amounts of $250.0 million as of both June 30, 2026 and December 31, 2025. Under the terms of the interest rate swap agreements, we receive from the counterparty interest on the notional amount based on one month Term SOFR and we pay to the counterparty a stated, fixed rate. The forward interest rate swap agreements have staggered maturities through February 28, 2030.
As of June 30, 2026, it was anticipated that $0.5 million of the gains, net of tax, related to interest rate swaps currently recorded in accumulated other comprehensive income (loss) will be reclassified into interest expense, net of interest income in our consolidated statement of operations within the next 12 months.
Indian Rupee Forward Contracts: We are party to Indian Rupee forward contracts that are scheduled to mature monthly through April 30, 2027. As of June 30, 2026 and December 31, 2025, the aggregate notional amounts of these contracts were Indian Rupee (INR) 0.69 billion, or $7.3 million, and Indian Rupee (INR) 1.47 billion, or $16.3 million, respectively, based on the exchange rates in effect as of each period end.
As of June 30, 2026, it was anticipated that all of the $0.2 million of losses, net of tax, related to these foreign currency forward contracts currently recorded in accumulated other comprehensive income (loss) will be reclassified into earnings in our consolidated statement of operations within the next 12 months.
Refer to Note 12 “Other Comprehensive Income (Loss)” for additional information on our cash flow hedges.
Derivatives not Designated as Hedging Instruments
Canadian Dollar Forward Contracts: Beginning in the first quarter of 2025, on a quarterly basis, we have entered into Canadian Dollar forward contracts that settle at the end of each quarter. As of June 30, 2026, we have one Canadian Dollar forward contract outstanding, with a notional amount of $20.0 million and a fair value of $0, that will settle on September 30, 2026. We did not designate any of these derivatives as accounting hedging instruments. Therefore, changes in the fair value of the derivatives are recorded to other income (expense), net in our consolidated statements of operations. During the three and six months ended June 30, 2026, we recognized $0.5 million and $1.1 million, respectively, of realized losses related to the settled forward contracts. During the three and six months ended June 30, 2025, we recognized $1.1 million and $0.9 million, respectively, of realized gains related to the settled forward contracts. From time to time, we may enter into additional Canadian Dollar forward contracts to continue to establish economic hedges against our foreign exchange rate risk.
The table below sets forth additional information relating to our derivative instruments recognized on our consolidated balance sheets as of June 30, 2026 and December 31, 2025.

Derivative Instrument | Balance Sheet Location |  | June 30, 2026 |  | December 31, 2025
Assets |  |  |  |  |
Cash Flow Hedges |  |  |  |  |
Interest rate swaps | Prepaid expenses and other current assets |  | $ | 791 |  |  | $ | 318 |
Interest rate swaps | Other non-current assets |  | 267 |  |  | 121 |
Foreign exchange forward contracts | Prepaid expenses and other current assets |  | 30 |  |  | — |
Total Assets |  |  | $ | 1,088 |  |  | $ | 439 |
Liabilities |  |  |  |  |
Cash Flow Hedges |  |  |  |  |
Interest rate swaps | Accrued expenses and other current liabilities |  | $ | 117 |  |  | $ | 1,023 |
Interest rate swaps | Deferred compensation and other liabilities |  | 505 |  |  | 2,809 |
Foreign exchange forward contracts | Accrued expenses and other current liabilities |  | 258 |  |  | 349 |
Total Liabilities |  |  | $ | 880 |  |  | $ | 4,181 |

All of our derivative instruments are transacted under International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis in our consolidated balance sheet.
13

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
11. Fair Value of Financial Instruments
Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:

Level 1 Inputs |  | Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 Inputs |  | Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs |  | Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2026 and December 31, 2025.

|  | Level 1 |  | Level 2 |  | Level 3 |  | Total
June 30, 2026 |  |  |  |  |  |  |  |
Assets: |  |  |  |  |  |  |  |
Interest rate swaps |  | $ | — |  |  | $ | 1,058 |  |  | $ | — |  |  | $ | 1,058 |
Convertible debt investment |  | — |  |  | — |  |  | 33,816 |  |  | 33,816 |
Foreign exchange forward contracts |  | — |  |  | 30 |  |  | — |  |  | 30 |
Deferred compensation assets |  | — |  |  | 55,432 |  |  | — |  |  | 55,432 |
Total assets |  | $ | — |  |  | $ | 56,520 |  |  | $ | 33,816 |  |  | $ | 90,336 |
Liabilities: |  |  |  |  |  |  |  |
Interest rate swaps |  | $ | — |  |  | $ | 622 |  |  | $ | — |  |  | $ | 622 |
Foreign exchange forward contracts |  | — |  |  | 258 |  |  | — |  |  | 258 |
Contingent consideration for business acquisitions |  | — |  |  | — |  |  | 34,134 |  |  | 34,134 |
Total liabilities |  | $ | — |  |  | $ | 880 |  |  | $ | 34,134 |  |  | $ | 35,014 |
December 31, 2025 |  |  |  |  |  |  |  |
Assets: |  |  |  |  |  |  |  |
Interest rate swaps |  | $ | — |  |  | $ | 439 |  |  | $ | — |  |  | $ | 439 |
Convertible debt investment |  | — |  |  | — |  |  | 34,079 |  |  | 34,079 |
Deferred compensation assets |  | — |  |  | 50,927 |  |  | — |  |  | 50,927 |
Total assets |  | $ | — |  |  | $ | 51,366 |  |  | $ | 34,079 |  |  | $ | 85,445 |
Liabilities: |  |  |  |  |  |  |  |
Interest rate swaps |  | $ | — |  |  | $ | 3,832 |  |  | $ | — |  |  | $ | 3,832 |
Foreign exchange forward contracts |  | — |  |  | 349 |  |  | — |  |  | 349 |
Contingent consideration for business acquisitions |  | — |  |  | — |  |  | 23,274 |  |  | 23,274 |
Total liabilities |  | $ | — |  |  | $ | 4,181 |  |  | $ | 23,274 |  |  | $ | 27,455 |

Interest rate swaps: The fair values of our interest rate swaps were derived using estimates to settle the interest rate swap agreements, which are based on the net present value of expected future cash flows on each leg of the swaps utilizing market-based inputs and a discount rate reflecting the risks involved. See Note 10 “Derivative Instruments and Hedging Activity” for additional information on our interest rate swaps.
14

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
Foreign exchange forward contracts: The fair values of our foreign exchange forward contracts were derived using estimates to settle the foreign exchange forward contracts agreements, which are based on the net present value of expected future cash flows on each contract utilizing market-based inputs, including both forward and spot prices, and a discount rate reflecting the risks involved. See Note 10 “Derivative Instruments and Hedging Activity” for additional information on our foreign exchange forward contracts.
Deferred compensation assets: We have a non-qualified deferred compensation plan (the “Plan”) for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets in our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.
Convertible debt investment: Since 2014, we have invested $40.9 million in the form of 1.69% convertible debt in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight, a U.S.-based company that partners with leading nonprofit universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. The convertible notes will mature on January 17, 2027, unless converted earlier.
To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the convertible notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security. We continue to monitor the key factors of our VIE analysis and the terms of the convertible notes to ensure our accounting treatment is appropriate. We have not identified any changes to Shorelight or our investment that would change our classification of the investment as an available-for-sale debt security.
The investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income (loss). To the extent any change in fair value is the result of a change in credit-related factors, such change is recorded to other income (expense), net in our consolidated statement of operations as a change to the allowance for credit losses. The carrying value is recorded in long-term investments in our consolidated balance sheets. We estimate the fair value of our investment using a scenario-based approach in the form of a hybrid analysis that consists of a Monte Carlo simulation model and an expected return analysis. The conclusion of value for our investment is based on the probability-weighted assessment of both scenarios. We estimate the allowance for credit losses as the difference between the present value of expected cash flows to be generated from the investment and the cost basis, limited to the difference between the fair value and cost basis.
The hybrid analysis and calculation of allowance for credit losses utilizes certain assumptions, all of which are Level 3 inputs. Specifically, the assumptions utilized in the hybrid analysis include the assumed holding period through the maturity date of January 17, 2027; the applicable waterfall distribution at the end of the expected holding period based on the rights and privileges of the various instruments; cash flow projections discounted at the risk-adjusted rate of 25.5% and 23.5% as of June 30, 2026 and December 31, 2025, respectively; and the concluded equity volatility of 47.5% and 40.0% as of June 30, 2026 and December 31, 2025, respectively. Additionally, the assumptions utilized in the calculation for the allowance for credit losses include the assumed holding period through the maturity date of January 17, 2027; the applicable waterfall distribution at the end of the expected holding period based on the rights and privileges of the various instruments; the concluded equity volatility of 47.5% and 40.0% as of June 30, 2026 and December 31, 2025, respectively; and cash flow projections discounted at the risk-adjusted rate in a range of 2.0% to 12.1%, with a weighted average of 8.8% and 8.7% as of June 30, 2026 and December 31, 2025, respectively. The weighted average risk-adjusted rate is calculated using the relative present value of expected cash flows. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment or the allowance for credit losses, which would result in different impacts to our consolidated balance sheet and statements of operations and other comprehensive income. Actual results may differ from our estimates.
The estimated fair value and allowance for credit losses of the convertible debt investment was $33.8 million and $9.3 million, respectively, as of June 30, 2026. The estimated fair value and allowance for credit losses of the convertible debt investment was $34.1 million and $10.4 million, respectively, as of December 31, 2025. Since our initial investment in 2014, we recognized a total pre-tax unrealized gain of $2.2 million within other comprehensive income (loss) and the $9.3 million allowance for credit losses within earnings. As of June 30, 2026 and December 31, 2025, our cost basis was $40.9 million.
15

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
The table below sets forth the changes in the balance of the convertible debt investment for the six months ended June 30, 2026.

|  | Convertible Debt Investment
Balance as of December 31, 2025 |  | $ | 34,079 |
Unrealized loss included in other comprehensive income (loss) |  | (1,330) |
Unrealized gain included in earnings |  | 1,067 |
Balance as of June 30, 2026 |  | $ | 33,816 |

Contingent consideration for business acquisitions: In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being measured or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and a discount rate which was in a range of 4.8% to 5.5%, with a weighted average of 5.0%, as of June 30, 2026. As of December 31, 2025, the discount rate was in a range of 4.3% to 5.1% with a weighted average of 4.9%. The weighted average discount rate was calculated using the relative fair values of the contingent consideration liabilities as of each period end. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded to other losses (gains), net in our consolidated statement of operations for that period. The carrying value is recorded in accrued expenses and other current liabilities or deferred compensation and other liabilities, based on the expected timing of payment, in our consolidated balance sheets. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates.
The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the six months ended June 30, 2026.

|  | Contingent Consideration for Business Acquisitions
Balance as of December 31, 2025 |  | $ | 23,274 |
Acquisition |  | 3,423 |
Payment |  | (253) |
Change in fair value |  | 7,690 |
Balance as of June 30, 2026(1) |  | $ | 34,134 |

(1) Of the $34.1 million contingent consideration liability, $17.3 million was recorded to accrued expenses and other current liabilities and $16.8 million was recorded to deferred compensation and other liabilities in our consolidated balance sheet.
See Note 4 "Acquisitions" and Note 14 "Commitments, Contingencies and Guarantees" for additional information on our acquisitions and contingent consideration liabilities.
Financial assets and liabilities not recorded at fair value on a recurring basis are as follows:
Equity Investment
In the fourth quarter of 2019, we invested $5.0 million in the preferred stock of a hospital-at-home company. In the second quarter of 2025, the hospital-at-home company merged with a third-party healthcare services provider; and in the second quarter of 2026, our equity investment was fully converted to shares of common stock of the same company in accordance with the terms of their most recent financing round.
To determine the appropriate accounting treatment for our equity investment since inception, we performed VIE analyses and concluded that the company does not meet the definition of a VIE. We also reviewed the characteristics of our investments to confirm that the equity securities do not warrant equity method accounting. After we reviewed all of the terms of the equity securities, we concluded the appropriate
16

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
accounting treatment for our investments to be that of equity securities with no readily determinable fair value. We have elected to continue to apply the measurement alternative and will continue to do so until the investment does not qualify to be so measured.
Under the measurement alternative, the investment is carried at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same company. On a quarterly basis, we review the information available to determine whether an orderly and observable transaction for same or similar equity instruments occurred or if factors indicate that a significant decrease in value has occurred. We remeasure to the fair value of the equity securities using such identified information with changes in the fair value recorded to other income (expense), net in our consolidated statement of operations. The carrying value of the equity investment is recorded in long-term investments in our consolidated balance sheets.
In the second quarter of 2026, we recognized a non-cash impairment loss of $2.2 million on our equity investment based on the valuation established in the most recent financing round. In the first quarter of 2025, we recognized a non-cash impairment charge of $4.2 million on our equity investment based on the valuation anticipated from the hospital-at-home company's merger. Upon the completion of the merger in the second quarter of 2025, we recognized an additional $0.8 million non-cash impairment charge based on the final valuation utilized in the merger. The non-cash impairment charges were recorded to other income (expense), net in our consolidated statement of operations. Since our initial investment in 2019, we have recognized cumulative unrealized losses of $33.5 million and cumulative unrealized gains of $28.6 million. As of June 30, 2026 and December 31, 2025, the carrying value of our equity investment was $0.1 million and $2.4 million, respectively, with a cost basis of $5.0 million.
Senior Secured Credit Facility
The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 8 “Financing Arrangements” for additional information on our senior secured credit facility.
Cash and Cash Equivalents and Other Financial Instruments
Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.
12. Other Comprehensive Income (Loss)
The tables below set forth the components of other comprehensive income (loss), net of tax, for the three and six months ended June 30, 2026 and 2025.

| Three Months Ended June 30, 2026 |  | Three Months Ended June 30, 2025
| Before Taxes |  | Tax (Expense) Benefit |  | Net of Taxes |  | Before Taxes |  | Tax (Expense) Benefit |  | Net of Taxes
Foreign currency translation adjustments | $ | (1,807) |  |  | $ | — |  |  | $ | (1,807) |  |  | $ | 2,749 |  |  | $ | — |  |  | $ | 2,749 |
Unrealized loss on investment | $ | (1,330) |  |  | $ | — |  |  | $ | (1,330) |  |  | $ | (4,236) |  |  | $ | (1,013) |  |  | $ | (5,249) |
Unrealized gain (loss) on cash flow hedges: |  |  |  |  |  |  |  |  |  |  |
Interest rate swaps: |  |  |  |  |  |  |  |  |  |  |
Change in fair value | $ | 2,123 |  |  | $ | (550) |  |  | $ | 1,573 |  |  | $ | (2,546) |  |  | $ | 659 |  |  | $ | (1,887) |
Reclassification adjustments into earnings | 29 |  |  | (7) |  |  | 22 |  |  | (399) |  |  | 104 |  |  | (295) |
Net unrealized gain (loss) on interest rate swaps | $ | 2,152 |  |  | $ | (557) |  |  | $ | 1,595 |  |  | $ | (2,945) |  |  | $ | 763 |  |  | $ | (2,182) |
Foreign exchange forward contracts: |  |  |  |  |  |  |  |  |  |  |
Change in fair value | $ | 64 |  |  | $ | (16) |  |  | $ | 48 |  |  | $ | 27 |  |  | $ | (7) |  |  | $ | 20 |
Reclassification adjustments into earnings | 344 |  |  | (90) |  |  | 254 |  |  | 65 |  |  | (17) |  |  | 48 |
Net unrealized gain (loss) on foreign exchange forward contracts | $ | 408 |  |  | $ | (106) |  |  | $ | 302 |  |  | $ | 92 |  |  | $ | (24) |  |  | $ | 68 |
Other comprehensive loss | $ | (577) |  |  | $ | (663) |  |  | $ | (1,240) |  |  | $ | (4,340) |  |  | $ | (274) |  |  | $ | (4,614) |

17

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

| Six Months Ended June 30, 2026 |  | Six Months Ended June 30, 2025
| Before Taxes |  | Tax (Expense) Benefit |  | Net of Taxes |  | Before Taxes |  | Tax (Expense) Benefit |  | Net of Taxes
Foreign currency translation adjustments | $ | (3,738) |  |  | $ | — |  |  | $ | (3,738) |  |  | $ | 3,284 |  |  | $ | — |  |  | $ | 3,284 |
Unrealized gain (loss) on investment | $ | (1,330) |  |  | $ | — |  |  | $ | (1,330) |  |  | $ | (18,429) |  |  | $ | 2,663 |  |  | $ | (15,766) |
Unrealized gain (loss) on cash flow hedges: |  |  |  |  |  |  |  |  |  |  |
Interest rate swaps: |  |  |  |  |  |  |  |  |  |  |
Change in fair value | $ | 3,797 |  |  | $ | (983) |  |  | $ | 2,814 |  |  | $ | (4,860) |  |  | $ | 1,257 |  |  | $ | (3,603) |
Reclassification adjustments into earnings | 32 |  |  | (8) |  |  | 24 |  |  | (1,332) |  |  | 347 |  |  | (985) |
Net unrealized gain (loss) on interest rate swaps | $ | 3,829 |  |  | $ | (991) |  |  | $ | 2,838 |  |  | $ | (6,192) |  |  | $ | 1,604 |  |  | $ | (4,588) |
Foreign exchange forward contracts: |  |  |  |  |  |  |  |  |  |  |
Change in fair value | $ | (484) |  |  | $ | 126 |  |  | $ | (358) |  |  | $ | 96 |  |  | $ | (25) |  |  | $ | 71 |
Reclassification adjustments into earnings | 605 |  |  | (158) |  |  | 447 |  |  | 230 |  |  | (60) |  |  | 170 |
Net unrealized gain (loss) on foreign exchange forward contracts | $ | 121 |  |  | $ | (32) |  |  | $ | 89 |  |  | $ | 326 |  |  | $ | (85) |  |  | $ | 241 |
Other comprehensive income (loss) | $ | (1,118) |  |  | $ | (1,023) |  |  | $ | (2,141) |  |  | $ | (21,011) |  |  | $ | 4,182 |  |  | $ | (16,829) |

The before tax amounts reclassified from accumulated other comprehensive income (loss) related to our interest rate swaps and foreign exchange forward contracts designated as cash flow hedges are recorded to interest expense, net of interest income and direct costs, respectively, on our consolidated statement of operations. The related tax amounts reclassified from accumulated other comprehensive income (loss) are recorded to income tax expense (benefit) on our consolidated statement of operations. Refer to Note 10 “Derivative Instruments and Hedging Activity” for additional information on our derivative instruments.
Accumulated other comprehensive income (loss), net of tax, includes the following components:

|  |  |  |  | Cash Flow Hedges |  |
| Foreign Currency Translation |  | Available-for-Sale Investment |  | Interest Rate Swaps |  | Foreign Exchange Forward Contracts |  | Total
Balance as of December 31, 2025 | $ | (4,222) |  |  | $ | 821 |  |  | $ | (2,504) |  |  | $ | (260) |  |  | $ | (6,165) |
Current period change | (3,738) |  |  | (1,330) |  |  | 2,838 |  |  | 89 |  |  | (2,141) |
Balance as of June 30, 2026 | $ | (7,960) |  |  | $ | (509) |  |  | $ | 334 |  |  | $ | (171) |  |  | $ | (8,306) |

13. Income Taxes
For the three months ended June 30, 2026, our effective tax rate was 27.2% as we recognized income tax expense of $11.7 million on income of $42.9 million. The effective tax rate of 27.2% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to certain nondeductible expense items and the inability to recognize tax benefits related to certain foreign and capital losses, partially offset by a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability.
For the three months ended June 30, 2025, our effective tax rate was 29.9% as we recognized income tax expense of $8.3 million on income of $27.7 million. The effective tax rate of 29.9% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to the establishment of a valuation allowance for a deferred tax asset recorded as the result of the capital loss on our investment in a hospital-at-home company as well as certain nondeductible expense items, partially offset by a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability.
For the six months ended June 30, 2026, our effective tax rate was 22.1% as we recognized income tax expense of $15.5 million on income of $70.0 million. The effective tax rate of 22.1% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2026 and a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability. These favorable items were partially offset by certain nondeductible expense items and the inability to recognize tax benefits related to certain foreign and capital losses.
18

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
For the six months ended June 30, 2025, our effective tax rate was 10.6% as we recognized income tax expense of $5.2 million on income of $49.2 million. The effective tax rate of 10.6% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2025. This favorable item was partially offset by the establishment of a valuation allowance for a deferred tax asset recorded as the result of the capital loss on our investment in a hospital-at-home company and certain nondeductible expenses.
14. Commitments, Contingencies and Guarantees
Lease Commitments
In the first quarter of 2026, we entered into the Seventh Amendment to the office lease agreement for our principal executive offices in Chicago, Illinois, which resulted in a non-cash gain on lease modification of $3.8 million. Among other items, this amendment i) extends the term of the lease from September 30, 2029 to September 30, 2037; ii) provides a renewal option to extend the lease for an additional five year period to September 30, 2042; iii) terminates the lease, effective September 30, 2026, with respect to certain leased spaces previously vacated; iv) provides abatement of certain future base rent payments and our pro rata share of operating expenses and taxes; and v) provides a tenant improvement allowance, a portion of which may be converted, at our option, to additional abatement of future base rent payments and our pro rata share of operating expenses and taxes.
Litigation
From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding or subject to any claim that, in the current opinion of management, could reasonably be expected to have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.
Guarantees
Guarantees in the form of letters of credit totaling $0.4 million were outstanding at both June 30, 2026 and December 31, 2025, which are used as security deposits for our office facilities.
In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. In connection with our second quarter 2026 business combination, we may be required to pay post-closing consideration to the sellers up to $11.6 million over a two-year term if specific revenues before reimbursable expenses targets are met. As of June 30, 2026 and December 31, 2025, the total estimated fair value of our outstanding contingent consideration liabilities was $34.1 million and $23.3 million, respectively. The remaining aggregate maximum amount of contingent consideration that may be paid is $55.4 million, which is payable, if earned, on a staggered basis through December 31, 2028. See Note 11 “Fair Value of Financial Instruments” for additional information on our contingent consideration liabilities.
To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.
15. Segment Information
We provide our services and products and manage our business under three reportable segments: Healthcare, Education, and Commercial, which align our business by industry.
•Healthcare
Our Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups; payors; and long-term care or post-acute providers. Our healthcare-focused consulting and managed services offerings include financial and operational performance improvement consulting, which spans revenue cycle, business operations and care delivery transformation; organizational transformation; revenue cycle, clinical and patient access managed services and outsourcing; financial and capital advisory consulting; and strategy consulting. Our healthcare-focused digital services span technology and analytic-related services, including core systems of record, such as enterprise health record (“EHR”), enterprise resource planning (“ERP”), enterprise performance management (“EPM”), and
19

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)
customer relationship management (“CRM”) systems; data management, artificial intelligence (“AI”) and automation; technology managed services; and payor core administration systems. We also have a portfolio of software products we deliver to the healthcare industry. In June 2025, we enhanced our consulting offerings through the acquisition of Eclipse Insights, a leading provider of revenue cycle solutions. In November 2025, we acquired the consulting services division of AXIOM to strengthen our digital-focused payor offerings. In June 2026, we strengthened our managed services offerings through the acquisition of RelateCare, a leading provider of AI-enabled clinical and patient access solutions.
•Education
Our Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. Our education and research-focused consulting and managed services offerings include our research-focused consulting and managed services; our strategy and operations consulting services, which span finance, accounting, operations and athletics to organization and talent strategy and student and academic strategy; and our advancement and fundraising consulting services, which were bolstered by the acquisitions of Advancement Resources and Halpin in March 2025. Our education and research-focused digital offerings span technology and analytic-related services, including core systems of record, such as student information, ERP, EPM, and CRM systems; data management, AI and automation; and technology managed services. Our education and research-focused product offerings include our Huron Research Suite, the leading software suite designed to facilitate and improve research administration service delivery and compliance.
•Commercial
Our Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Our Commercial professionals work primarily with seven primary buyers: the chief executive officer, the chief financial officer, the chief strategy officer, the chief human resources officer, the chief operating officer, the chief risk officer, and organizational advisors, including lenders and law firms. We have a deep focus on serving organizations in the financial services, industrials and manufacturing, and energy and utilities industries and the public sector while opportunistically serving commercial industries more broadly, including professional and business services, life sciences, consumer products, and retail. Our Commercial professionals use their deep industry, functional and technical expertise to deliver our digital services, financial and capital advisory (special situation advisory and corporate finance advisory) consulting services, regulatory compliance and risk management consulting and managed services, strategy and operations consulting services, and financial and operational performance improvement consulting services. In the third quarter of 2025, we bolstered our Commercial consulting offerings through the acquisitions of Treliant, a global financial services consulting and managed services firm, and WP&C, a leading strategy and operations consulting firm specializing in driving operational efficiency and improved growth and profitability.
Our chief operating decision maker (“CODM”), who is our chief executive officer, manages the business under these three reportable segments. Our CODM uses segment operating income in the annual budgeting and quarterly forecasting process as well as on a monthly basis for evaluating the performance of each segment and making decisions about allocating capital and other resources to each segment. Our CODM does not evaluate segments using asset information.
Segment operating income consists of the revenues generated by a segment, less operating expenses that are incurred directly by the segment. Unallocated costs include corporate costs related to administrative functions that are performed in a centralized manner, as well as restructuring charges, other gains and losses, depreciation and amortization, and interest expense that are not attributable to a particular segment. The administrative function costs include corporate office support costs, office facility costs, costs related to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management.
The table below sets forth information about our reportable segments for the three and six months ended June 30, 2026 and 2025, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements. We do not present financial information by geographic area because the financial results of our international operations are not significant to our consolidated financial statements.

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Healthcare: |  |  |  |  |  |  |
Revenues before reimbursable expenses | $ | 232,303 |  |  | $ | 197,822 |  |  | $ | 457,504 |  |  | $ | 396,312 |

20

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Reimbursable expenses | 4,549 |  |  | 5,449 |  |  | 8,533 |  |  | 10,280 |
Total revenues | 236,852 |  |  | 203,271 |  |  | 466,037 |  |  | 406,592 |
Operating expenses: |  |  |  |  |  |  |
Direct costs | 151,107 |  |  | 125,759 |  |  | 298,701 |  |  | 256,071 |
Reimbursable expenses | 4,549 |  |  | 5,449 |  |  | 8,533 |  |  | 10,280 |
Selling, general and administrative expenses | 10,087 |  |  | 10,847 |  |  | 21,454 |  |  | 21,178 |
Depreciation and amortization | 1,409 |  |  | 1,568 |  |  | 3,270 |  |  | 3,135 |
Other segment items(1) | (202) |  |  | (3) |  |  | 224 |  |  | (39) |
Total segment operating expenses | 166,950 |  |  | 143,620 |  |  | 332,182 |  |  | 290,625 |
Segment operating income | $ | 69,902 |  |  | $ | 59,651 |  |  | $ | 133,855 |  |  | $ | 115,967 |
Education: |  |  |  |  |  |  |
Revenues before reimbursable expenses | $ | 139,375 |  |  | $ | 129,301 |  |  | $ | 266,843 |  |  | $ | 252,049 |
Reimbursable expenses | 2,813 |  |  | 2,385 |  |  | 4,956 |  |  | 4,653 |
Total revenues | 142,188 |  |  | 131,686 |  |  | 271,799 |  |  | 256,702 |
Operating expenses: |  |  |  |  |  |  |
Direct costs | 92,034 |  |  | 86,984 |  |  | 182,716 |  |  | 177,349 |
Reimbursable expenses | 2,813 |  |  | 2,385 |  |  | 4,956 |  |  | 4,653 |
Selling, general and administrative expenses | 8,211 |  |  | 8,842 |  |  | 15,568 |  |  | 17,204 |
Depreciation and amortization | 1,688 |  |  | 1,146 |  |  | 2,981 |  |  | 2,115 |
Other segment items(1) | 26 |  |  | — |  |  | 584 |  |  | (8) |
Total segment operating expenses | 104,772 |  |  | 99,357 |  |  | 206,805 |  |  | 201,313 |
Segment operating income | $ | 37,416 |  |  | $ | 32,329 |  |  | $ | 64,994 |  |  | $ | 55,389 |
Commercial: |  |  |  |  |  |  |
Revenues before reimbursable expenses | $ | 93,958 |  |  | $ | 75,382 |  |  | $ | 185,001 |  |  | $ | 149,834 |
Reimbursable expenses | 2,044 |  |  | 1,416 |  |  | 3,972 |  |  | 2,768 |
Total revenues | 96,002 |  |  | 76,798 |  |  | 188,973 |  |  | 152,602 |
Operating expenses: |  |  |  |  |  |  |
Direct costs | 67,781 |  |  | 56,214 |  |  | 137,369 |  |  | 113,393 |
Reimbursable expenses | 2,044 |  |  | 1,416 |  |  | 3,972 |  |  | 2,768 |
Selling, general and administrative expenses | 6,390 |  |  | 6,316 |  |  | 12,677 |  |  | 12,068 |
Depreciation and amortization | 11 |  |  | 236 |  |  | 72 |  |  | 472 |
Other segment items(1) | 24 |  |  | 109 |  |  | 235 |  |  | 98 |
Total segment operating expenses | 76,250 |  |  | 64,291 |  |  | 154,325 |  |  | 128,799 |
Segment operating income | $ | 19,752 |  |  | $ | 12,507 |  |  | $ | 34,648 |  |  | $ | 23,803 |
Total Huron: |  |  |  |  |  |  |
Revenues before reimbursable expenses | $ | 465,636 |  |  | $ | 402,505 |  |  | $ | 909,348 |  |  | $ | 798,195 |
Reimbursable expenses | 9,406 |  |  | 9,250 |  |  | 17,461 |  |  | 17,701 |
Total revenues | $ | 475,042 |  |  | $ | 411,755 |  |  | $ | 926,809 |  |  | $ | 815,896 |
Segment operating income | $ | 127,070 |  |  | $ | 104,487 |  |  | $ | 233,497 |  |  | $ | 195,159 |
Items not allocated at the segment level: |  |  |  |  |  |  |
Unallocated corporate expenses | 65,370 |  |  | 54,281 |  |  | 125,400 |  |  | 106,652 |

21

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Other losses (gains) | 3,850 |  |  | (71) |  |  | 7,690 |  |  | (71) |
Restructuring charges | 562 |  |  | 455 |  |  | 30 |  |  | 1,847 |
Depreciation and amortization | 7,040 |  |  | 4,168 |  |  | 13,546 |  |  | 8,345 |
Operating income | 50,248 |  |  | 45,654 |  |  | 86,831 |  |  | 78,386 |
Other expense, net | (7,340) |  |  | (17,946) |  |  | (16,857) |  |  | (29,226) |
Income before taxes | $ | 42,908 |  |  | $ | 27,708 |  |  | $ | 69,974 |  |  | $ | 49,160 |

(1)Other segment items in each segment consists of restructuring charges for all periods presented.
The following tables illustrate the disaggregation of segment total revenues and segment revenues before reimbursable expenses (RBR) by our two principal capabilities: i) Consulting and Managed Services and ii) Digital, and includes a reconciliation to consolidated total revenues and consolidated RBR. We manage our business on the basis of RBR, which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that we bill to our clients at cost.

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
Total Revenues by Capability |  | 2026 |  | 2025 |  | 2026 |  | 2025
Healthcare: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 177,837 |  |  | $ | 150,148 |  |  | $ | 352,981 |  |  | $ | 297,181 |
Digital |  | 59,015 |  |  | 53,123 |  |  | 113,056 |  |  | 109,411 |
Total revenues |  | $ | 236,852 |  |  | $ | 203,271 |  |  | $ | 466,037 |  |  | $ | 406,592 |
Education: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 66,749 |  |  | $ | 68,351 |  |  | $ | 130,247 |  |  | $ | 133,009 |
Digital |  | 75,439 |  |  | 63,335 |  |  | 141,552 |  |  | 123,693 |
Total revenues |  | $ | 142,188 |  |  | $ | 131,686 |  |  | $ | 271,799 |  |  | $ | 256,702 |
Commercial: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 36,405 |  |  | $ | 16,225 |  |  | $ | 73,907 |  |  | $ | 33,317 |
Digital |  | 59,597 |  |  | 60,573 |  |  | 115,066 |  |  | 119,285 |
Total revenues |  | $ | 96,002 |  |  | $ | 76,798 |  |  | $ | 188,973 |  |  | $ | 152,602 |
Total Huron: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 280,991 |  |  | $ | 234,724 |  |  | $ | 557,135 |  |  | $ | 463,507 |
Digital |  | 194,051 |  |  | 177,031 |  |  | 369,674 |  |  | 352,389 |
Total revenues |  | $ | 475,042 |  |  | $ | 411,755 |  |  | $ | 926,809 |  |  | $ | 815,896 |

22

Table of Contents
HURON CONSULTING GROUP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Tabular amounts in thousands, except per share amounts)
(Unaudited)

|  | Three Months Ended June 30, |  | Six Months Ended June 30,
Revenues before Reimbursable Expenses by Capability |  | 2026 |  | 2025 |  | 2026 |  | 2025
Healthcare: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 174,450 |  |  | $ | 145,755 |  |  | $ | 346,641 |  |  | $ | 289,129 |
Digital |  | 57,853 |  |  | 52,067 |  |  | 110,863 |  |  | 107,183 |
Total revenues before reimbursable expenses |  | $ | 232,303 |  |  | $ | 197,822 |  |  | $ | 457,504 |  |  | $ | 396,312 |
Education: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 65,585 |  |  | $ | 67,329 |  |  | $ | 128,045 |  |  | $ | 130,873 |
Digital |  | 73,790 |  |  | 61,972 |  |  | 138,798 |  |  | 121,176 |
Total revenues before reimbursable expenses |  | $ | 139,375 |  |  | $ | 129,301 |  |  | $ | 266,843 |  |  | $ | 252,049 |
Commercial: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 35,886 |  |  | $ | 16,038 |  |  | $ | 72,852 |  |  | $ | 33,041 |
Digital |  | 58,072 |  |  | 59,344 |  |  | 112,149 |  |  | 116,793 |
Total revenues before reimbursable expenses |  | $ | 93,958 |  |  | $ | 75,382 |  |  | $ | 185,001 |  |  | $ | 149,834 |
Total Huron: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 275,921 |  |  | $ | 229,122 |  |  | $ | 547,538 |  |  | $ | 453,043 |
Digital |  | 189,715 |  |  | 173,383 |  |  | 361,810 |  |  | 345,152 |
Total revenues before reimbursable expenses |  | $ | 465,636 |  |  | $ | 402,505 |  |  | $ | 909,348 |  |  | $ | 798,195 |

For the three and six months ended June 30, 2026 and 2025, substantially all of our revenues were recognized over time. During the three and six months ended June 30, 2026 and 2025, no single client generated greater than 10% of our consolidated total revenues. At June 30, 2026 and December 31, 2025, no single client accounted for greater than 10% of our combined balance of receivables from clients, net and unbilled services, net.
23

Table of Contents

ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Huron,” “Company,” “we,” “us” and “our” refer to Huron Consulting Group Inc. and its subsidiaries.
Statements in this Quarterly Report on Form 10-Q that are not historical in nature, including those concerning the Company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “positions,” “continues,” “goals,” “guidance,” or “outlook,” or similar expressions. These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: failure to achieve expected utilization rates, billing rates, and the necessary number of revenue-generating professionals; our ability to realize the expected benefits and potential opportunities of artificial intelligence (AI); inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn or volatility in market conditions, including as a result of current global trade tensions and/or tariffs. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under Item 1A. “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2025 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.
OVERVIEW
Huron is a global professional services firm that collaborates with organizations to help solve their most complex challenges and achieve their most ambitious goals. Working across the private and public sectors, we partner closely with clients to improve performance, accelerate transformation, and unlock new opportunities for growth.
Our clients choose us because of our deep industry and technical expertise and proven track record of turning sound strategies into action. By combining practical experience, innovative thinking, and advanced analytics and technology, Huron helps organizations translate today’s ideas into tangible results and long-term value.
OUR STRATEGY
The combination of our deep industry expertise and breadth of our offerings is the foundation of our growth strategy and why our clients choose Huron as their trusted advisor. Key focus areas of our growth strategy include:
•Accelerating Growth in Healthcare and Education: Huron holds leading market positions in healthcare and education, providing comprehensive offerings to the largest health systems, academic medical centers, colleges and universities, and research institutes in the United States and abroad. The Company will continue to broaden its portfolio of offerings in healthcare and education to drive even greater impact on current and new clients as the needs in those industries further evolve due to competitive, technological, regulatory, financial, and broader market changes.
•Growing Presence in Commercial Industries: Through its deep industry and capability expertise and nimble approach, Huron has grown its client base and expanded its credentials in the commercial industries. Huron’s commercial industry strategy has increased the diversification of the Company’s portfolio and end markets while expanding the range of capabilities it can deliver to clients, providing new avenues for growth and an important balance to its healthcare and education focus.
•Rapidly Growing Global Digital Capability: As data, technology and artificial intelligence (“AI”) evolve across industries, Huron’s ability to provide a broad portfolio of digital offerings that support the strategic and operational needs of its clients globally is at the foundation of the Company’s strategy. Huron will continue to advance its integrated digital platform to support its strong growth trajectory.
•Solid Foundation for Margin Expansion: The Company continues to be well-positioned to further achieve margin expansion as well as strong annual adjusted diluted earnings per share growth. We are committed to operating income margin expansion by seeking to grow the areas of the business that provide the most attractive returns, improving our pricing realization and the operational efficiency of our delivery for clients, utilizing our global delivery platform across regions, and scaling our selling, general, and administrative expenses as we grow.
•Strong Balance Sheet and Cash Flows: A resilient, flexible balance sheet is the foundation of our financial strength, and strong free cash flows have and will continue to be the hallmark of Huron’s business model. The Company is committed to deploying capital in a strategic
24

Table of Contents
and balanced way, including returning capital to shareholders and executing strategic, tuck-in acquisitions while prudently managing our leverage ratio.
OUR SERVICES AND PRODUCTS
We provide our services and products and manage our business under three operating segments - Healthcare, Education, and Commercial - which aligns our business by industry. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services, industrials and manufacturing, energy and utilities, and the public sector. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital, which are methods by which we deliver our services and products.
Operating Industries
•Healthcare
Our Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups; payors; and long-term care or post-acute providers. Our healthcare-focused consulting and managed services offerings include financial and operational performance improvement consulting, which spans revenue cycle, business operations and care delivery transformation; organizational transformation; revenue cycle, clinical and patient access managed services and outsourcing; financial and capital advisory consulting; and strategy consulting. Our healthcare-focused digital services span technology and analytic-related services, including core systems of record, such as enterprise health record (“EHR”), enterprise resource planning (“ERP”), enterprise performance management (“EPM”), and customer relationship management (“CRM”) systems; data management, artificial intelligence (“AI”) and automation; technology managed services; and payor core administration systems. We also have a portfolio of software products we deliver to the healthcare industry. In June 2025, we enhanced our consulting offerings through the acquisition of Eclipse Insights, a leading provider of revenue cycle solutions. In November 2025, we acquired the consulting services division of AXIOM to strengthen our digital-focused payor offerings. In June 2026, we strengthened our managed services offerings through the acquisition of RelateCare, a leading provider of AI-enabled clinical and patient access solutions.
•Education
Our Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. Our education and research-focused consulting and managed services offerings include our research-focused consulting and managed services; our strategy and operations consulting services, which span finance, accounting, operations and athletics to organization and talent strategy and student and academic strategy; and our advancement and fundraising consulting services, which were bolstered by the acquisitions of Advancement Resources and Halpin in March 2025. Our education and research-focused digital offerings span technology and analytic-related services, including core systems of record, such as student information, ERP, EPM, and CRM systems; data management, AI and automation; and technology managed services. Our education and research-focused product offerings include our Huron Research Suite, the leading software suite designed to facilitate and improve research administration service delivery and compliance.
•Commercial
Our Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Our Commercial professionals work primarily with seven primary buyers: the chief executive officer, the chief financial officer, the chief strategy officer, the chief human resources officer, the chief operating officer, the chief risk officer, and organizational advisors, including lenders and law firms. We have a deep focus on serving organizations in the financial services, industrials and manufacturing, and energy and utilities industries and the public sector while opportunistically serving commercial industries more broadly, including professional and business services, life sciences, consumer products, and retail. Our Commercial professionals use their deep industry, functional and technical expertise to deliver our digital services, financial and capital advisory (special situation advisory and corporate finance advisory) consulting services, regulatory compliance and risk management consulting and managed services, strategy and operations consulting services, and financial and operational performance improvement consulting services. In the third quarter of 2025, we bolstered our Commercial consulting offerings through the acquisitions of Treliant, a global financial services consulting and managed services firm, and WP&C, a leading strategy and operations consulting firm specializing in driving operational efficiency and improved growth and profitability.
Capabilities
Within each of our operating segments, we provide our offerings under two principal capabilities: i) Consulting and Managed Services and ii) Digital.
25

Table of Contents
•Consulting and Managed Services
Our Consulting and Managed Services capabilities represent our management consulting services, managed services (excluding technology-related managed services) and outsourcing services delivered across industries. Our Consulting and Managed Services experts help our clients address a variety of strategic, operational, financial, people and organizational-related challenges. These services are often combined with technology, analytic, and data- and AI-driven solutions powered by our Digital capability to support long-term relationships with our clients and drive lasting impact. Examples include the areas of revenue cycle, clinical and patient access and research administration managed services and outsourcing at our healthcare, education and research-focused clients, where our projects are often coupled with our digital services and product offerings and management consulting services to sustain improved performance.
•Digital
Our Digital capabilities represent our technology and analytics services, including technology-related managed services, and software products delivered across industries. Our Digital experts help clients address a variety of business challenges, including, but not limited to, the design and implementation of technologies to accelerate transformation, facilitate data-driven decision making, operate more efficiently by leveraging AI- and automation-enabled workflows, and improve customer and employee experiences. We have invested organically and inorganically to expand our Digital offerings, which now span beyond core systems of record, such as ERP systems, into a broader set of administrative systems, including supply chain management, industry-specific systems of record and systems of engagement that act as the “digital front door” to an organization. We have grown our data, analytics, AI and automation offerings to deliver a unified and actionable technology ecosystem for our clients.
We have expanded our ecosystem to work with more than 25 technology partners. For example, we are a Leading Modern Oracle Network Partner; a Summit-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org; a Workday Services, Preferred Channel, Extend, and Application Management Services Partner; a Microsoft Solutions Partner; an Amazon Web Services consulting partner; an Informatica Platinum Partner; and an SAP Concur implementation partner.
We have also grown our proprietary software product portfolio to address our clients' challenges with solutions that expand our base of recurring revenue and further differentiate our consulting, digital and managed services offerings. Our product portfolio bundles our deep industry expertise and unique intellectual property together to serve our clients outside of our traditional consulting offerings. Our product portfolio includes, among others: Huron Research Suite, the leading software suite designed to facilitate and improve research administration service delivery and compliance; Huron Intelligence™ Rounding, the #1 ranked Digital Rounding solution in the 2025 Best in KLAS® report; and Huron Intelligence™ Analytic Suite in Healthcare, a predictive analytics suite to improve care delivery while lowering costs.
COMPONENTS OF OPERATING RESULTS
Total Revenues
Revenues before Reimbursable Expenses (RBR)
Revenues before reimbursable expenses (RBR) are primarily generated by our employees who provide consulting and other professional services to our clients and are billable to our clients based on the number of hours worked, services provided, or achieved outcomes. We refer to these employees as our revenue-generating professionals. RBR is primarily driven by the number of revenue-generating professionals we employ as well as the total value, scope, and terms of the consulting contracts under which they provide services. We also engage independent contractors to supplement our revenue-generating professionals on client engagements as needed.
We generate our RBR from providing professional services and software products under the following four types of billing arrangements: fixed-fee; time-and-expense; performance-based; and software support, maintenance and subscriptions.
•Fixed-fee: In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements.
•Time-and-expense: Under time-and-expense billing arrangements, we invoice our clients based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include speaking engagements, conferences and publications purchased by our clients.
•Performance-based: In performance-based billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we earn a success fee when and if certain predefined outcomes occur. Often, performance-based fees supplement our fixed-fee or time-and-expense engagements. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide.
26

Table of Contents
•Software support, maintenance and subscriptions: We generate subscription revenue from our cloud-based analytic tools and solutions including our cloud-based revenue cycle management software and research administration and compliance software. Additionally, clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. Software support, maintenance and subscription revenues are recognized ratably over the support or subscription period. These fees are generally billed in advance and included in deferred revenues until recognized as revenue.
Time-and-expense engagements do not provide us with a high degree of predictability as to performance in future periods. Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.
Our quarterly results are impacted principally by the total value, scope, and terms of our client contracts, the number of our revenue-generating professionals who are available to work, our revenue-generating professionals' utilization rate, and the bill rates we charge our clients. Our utilization rate can be negatively affected by increased hiring because there is generally a transition period for new professionals that results in a temporary drop in our utilization rate. Our utilization rate can also be affected by seasonal variations in the demand for our services from our clients. For example, during the third and fourth quarters of the year, vacations taken by our clients can result in the deferral of activity on existing and new engagements, which would negatively affect our utilization rate. The number of business work days is also affected by the number of vacation days taken by our consultants and holidays in each quarter. We typically have fewer business work days available in the fourth quarter of the year, which can impact revenues during that period.
Reimbursable Expenses
Reimbursable expenses that are billed to clients, primarily relating to travel and out-of-pocket expenses incurred in connection with client engagements, are included in total revenues. We manage our business on the basis of revenues before reimbursable expenses (RBR), which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that we bill to our clients at cost.
Operating Expenses
Our most significant expenses are costs classified as direct costs. Direct costs primarily consist of compensation costs for our revenue-generating professionals, which includes salaries, performance bonuses, share-based compensation, signing and retention bonuses, payroll taxes and benefits. Direct costs also include fees paid to independent contractors that we retain to supplement our revenue-generating professionals, typically on an as-needed basis for specific client engagements, and technology costs, product and event costs, and commissions. Direct costs exclude amortization of intangible assets and software development costs and reimbursable expenses, both of which are separately presented in our consolidated statements of operations.
Selling, general and administrative expenses primarily consists of compensation costs for our support personnel, which includes salaries, performance bonuses, share-based compensation, signing and retention bonuses, payroll taxes, benefits and deferred compensation expense attributable to the change in market value of our deferred compensation liability. Changes in the market value of our deferred compensation liability are offset with the changes in market value of the investments that are used to fund our deferred compensation liability, which are recorded within other income (expense), net. Also included in selling, general and administrative expenses are third-party professional fees, software licenses and data hosting expenses, rent and other office-related expenses, sales and marketing expenses, recruiting and training expenses, and practice administration and meeting expenses.
Other operating expenses include restructuring charges, other gains and losses, depreciation expense, and amortization expense related to internally developed software costs and intangible assets acquired in business combinations.
Segment Results
Segment operating income consists of the revenues generated by a segment, less operating expenses that are incurred directly by the segment. Unallocated corporate expenses not allocated at the segment level include costs related to administrative functions that are performed in a centralized manner, as well as restructuring charges, depreciation and amortization, and interest expense that are not attributable to a particular segment. The administrative function costs include corporate office support costs, office facility costs, costs related to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, and costs related to overall corporate management.
Non-GAAP Financial Measures
We also assess our results of operations using the following non-GAAP financial measures: earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of RBR, adjusted net income, and adjusted diluted earnings per share. These non-GAAP financial measures differ from GAAP because they exclude a number of items required by GAAP, each discussed below. These non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows, or liquidity prepared in accordance with GAAP. Our non-GAAP financial measures may be defined differently from time to time and may
27

Table of Contents
be defined differently than similar terms used by other companies, and accordingly, care should be exercised in understanding how we define our non-GAAP financial measures.
Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does, if they so choose, and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results.
These non-GAAP financial measures include adjustments for the following items:
Amortization of intangible assets: We exclude the effect of amortization of intangible assets from the calculation of adjusted net income, as it is inconsistent in its amount and frequency and is significantly affected by the timing and size of our acquisitions.
Restructuring charges: We have incurred charges due to restructuring various parts of our business. These restructuring charges have primarily consisted of costs associated with office space consolidations, including lease impairment charges and accelerated depreciation on lease-related property and equipment, and employee severance charges. We exclude the effect of the restructuring charges from our non-GAAP financial measures to permit comparability with periods that were not impacted by these items. We do not include normal, recurring, cash operating expenses in our restructuring charges.
Other losses (gains), net: We exclude the effects of other losses and gains, which primarily relate to changes in the estimated fair value of our liabilities for contingent consideration related to business acquisitions and litigation settlement losses and gains, to permit comparability with periods that are not impacted by these items. These items are recorded as a component of other losses (gains), net on our consolidated statement of operations.
Transaction-related expenses: We exclude the impact of third-party advisory, legal, and accounting fees and other corporate costs incurred directly related to the evaluation and/or consummation of business acquisitions to permit comparability with prior periods as these costs are inconsistent in their amount and frequency and are significantly affected by the timing and size of our acquisitions.
Unrealized losses (gains) on long-term investments, net: We exclude the effect of unrealized losses and gains related to our long-term investments, which include changes to the credit allowance recognized on our convertible debt investment in a third-party as well as changes in the fair value of our equity investment in a hospital-at-home company arising from observable price changes or impairment charges. These unrealized losses and gains are included as a component of other income (expense), net on our consolidated statement of operations. We believe these unrealized losses and gains are not indicative of the ongoing performance of our business and their exclusion permits comparability with prior periods.
Losses (gains) on sales of businesses: We exclude the effect of non-operating losses and gains recognized as a result of sales of businesses as they are infrequent, management believes that these items are not indicative of the ongoing performance of our business, and their exclusion permits comparability with periods that were not impacted by such items. The 2026 gain relates to the divestiture of a business within our Commercial segment completed in the first quarter of 2026. The divested business was not significant to our consolidated financial statements for any period presented.
Foreign currency transaction losses (gains), net: We exclude the effect of foreign currency transaction losses and gains from the calculation of adjusted EBITDA because the amount of each loss or gain is significantly affected by changes in foreign exchange rates.
Tax effect of adjustments: The non-GAAP income tax adjustment reflects the incremental tax impact applicable to the non-GAAP adjustments.
Income tax expense, interest expense, net of interest income, depreciation and amortization: We exclude the effects of income tax expense, interest expense, net of interest income, and depreciation and amortization in the calculation of EBITDA, as these are customary exclusions as defined by the calculation of EBITDA to arrive at meaningful earnings from core operations excluding the effect of such items. We include, within the depreciation and amortization adjustment, the amortization of capitalized implementation costs of our ERP and other related software, which is included within selling, general and administrative expenses in our consolidated statements of operations.
Revenue-Generating Professionals
Our revenue-generating professionals consist of our full-time consultants who generate revenues based on the number of hours worked; full-time equivalents, which consists of coaches and their support staff within the culture and organizational excellence solution, consultants who work variable schedules as needed by clients, and full-time employees who provide software support and maintenance services to clients; and our
28

Table of Contents
Managed Services professionals who provide revenue cycle, clinical and patient access managed services, research administration managed services and outsourcing at our healthcare, education and research-focused clients.
Utilization Rate
The utilization rate of our revenue-generating professionals is calculated by dividing the number of hours our billable consultants worked on client assignments during a period by the total available working hours for these billable consultants during the same period. Available working hours are determined by the standard hours worked by each billable consultant, adjusted for part-time hours, and U.S. standard work weeks. Available working hours exclude local country holidays and vacation days. Utilization rates are presented for our revenue-generating professionals who primarily bill on an hourly basis. We do not present utilization rates for our Managed Services professionals as most of the revenues generated by these employees are not billed on an hourly basis.
RESULTS OF OPERATIONS
Executive Highlights
Highlights from the second quarter of 2026 include the following:
•Revenues before reimbursable expenses (RBR) increased $63.1 million, or 15.7%, to $465.6 million for the second quarter of 2026 from $402.5 million for the second quarter of 2025.
•Net income as a percentage of total revenues increased to 6.6% for the second quarter of 2026, compared to 4.7% for the second quarter of 2025. Results for the second quarter of 2025 include an $8.2 million non-cash credit-related impairment charge, net of tax, related to our convertible debt investment in a third-party.
•Adjusted EBITDA as a percentage of RBR increased to 15.6% for the second quarter of 2026, compared to 15.1% for the second quarter of 2025.
•Diluted EPS increased 75.2% to $1.91 for the second quarter of 2026 from $1.09 for the second quarter of 2025. Results for the second quarter of 2025 include the non-cash credit-related impairment charge on our convertible debt investment, which had an unfavorable $0.46 impact on diluted EPS in the prior year period.
•Adjusted diluted EPS increased 30.2% to $2.46 for the second quarter of 2026, compared to $1.89 for the second quarter of 2025.
•Returned $53.1 million to shareholders in the second quarter of 2026 by repurchasing 438,456 shares of our common stock.
RBR increased $63.1 million, or 15.7%, to $465.6 million for the second quarter of 2026 from $402.5 million for the second quarter of 2025. This growth reflects strength in demand across all three of our operating segments and across both the Consulting and Managed Services and Digital capabilities. The increase includes $19.5 million of incremental RBR from our acquisitions completed since March 31, 2025. Excluding the $19.5 million of incremental RBR from our acquisitions, RBR grew 10.8% organically.
RBR within our Consulting and Managed Services capability increased $46.8 million, or 20.4%, in the second quarter of 2026 to $275.9 million, compared to $229.1 million in the second quarter of 2025; and reflected strengthened demand in our Healthcare and Commercial segments. The increase includes $17.5 million of incremental RBR from our acquisitions of WP&C, RelateCare, Treliant, and Eclipse Insights. The utilization rate within our Consulting capability increased to 81.3% in the second quarter of 2026, compared to 77.0% in the second quarter of 2025.
RBR within our Digital capability increased $16.3 million, or 9.4%, in the second quarter of 2026 to $189.7 million, compared to $173.4 million in the second quarter of 2025; and reflected an increase in RBR in our Education and Healthcare segments. The increase includes $1.9 million of incremental RBR from our acquisition of AXIOM. The utilization rate within our Digital capability increased to 81.8% in the second quarter of 2026, compared to 77.8% in the second quarter of 2025.
Our total number of revenue-generating professionals, excluding Managed Services professionals, increased 7.0% to 5,335 as of June 30, 2026, compared to 4,986 as of June 30, 2025, as a result of the acquisitions completed since the second quarter of 2025 and hiring to support the overall increase in demand for our services. The number of Managed Services professionals increased to 3,913 as of June 30, 2026 from 1,895 as of June 30, 2025. This increase includes our acquisition of RelateCare in June 2026, which added approximately 1,100 Managed Services professionals. We proactively plan and manage the size and composition of our workforce and take actions as needed to address changes in the anticipated demand for our services as employee compensation costs are the most significant portion of our operating expenses.
29

Table of Contents
Net income increased $11.8 million, or 60.8%, to $31.2 million for the three months ended June 30, 2026 from $19.4 million for the same period last year. The second quarter of 2025 includes the $8.2 million non-cash credit-related impairment charge, net of tax, related to our convertible debt investment in a third-party. Diluted earnings per share for the second quarter of 2026 increased 75.2% to $1.91 from $1.09 for the second quarter of 2025 driven by the increase in net income as well as a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan. The non-cash credit-related impairment charge on our convertible debt investment recognized in the second quarter of 2025 had an unfavorable $0.46 impact on diluted EPS in the prior year period. Adjusted diluted earnings per share, which excludes the impact of the non-cash impairment charge in 2025, increased 30.2% to $2.46 for the second quarter of 2026, compared to $1.89 for the second quarter of 2025.
Adjusted EBITDA increased $12.1 million, or 19.9%, to $72.6 million, or 15.6% of RBR, for the second quarter of 2026, compared to $60.6 million, or 15.1% of RBR, for the same period last year.
In the second quarter of 2026, we deployed $53.1 million of capital to repurchase 438,456 shares of our common stock, representing 2.5% of our common stock outstanding as of December 31, 2025.
Summary of Results
The following tables set forth, for the periods indicated, selected segment and consolidated operating results and other operating data, including non-GAAP financial measures.

Segment and Consolidated Operating Results (in thousands, except per share amounts): |  | Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Healthcare: |  |  |  |  |  |  |  |
Revenues before reimbursable expenses |  | $ | 232,303 |  |  | $ | 197,822 |  |  | $ | 457,504 |  |  | $ | 396,312 |
Operating income |  | $ | 69,902 |  |  | $ | 59,651 |  |  | $ | 133,855 |  |  | $ | 115,967 |
Segment operating income as a percentage of segment RBR |  | 30.1 | % |  | 30.2 | % |  | 29.3 | % |  | 29.3 | %
Education: |  |  |  |  |  |  |  |
Revenues before reimbursable expenses |  | $ | 139,375 |  |  | $ | 129,301 |  |  | $ | 266,843 |  |  | $ | 252,049 |
Operating income |  | $ | 37,416 |  |  | $ | 32,329 |  |  | $ | 64,994 |  |  | $ | 55,389 |
Segment operating income as a percentage of segment RBR |  | 26.8 | % |  | 25.0 | % |  | 24.4 | % |  | 22.0 | %
Commercial: |  |  |  |  |  |  |  |
Revenues before reimbursable expenses |  | $ | 93,958 |  |  | $ | 75,382 |  |  | $ | 185,001 |  |  | $ | 149,834 |
Operating income |  | $ | 19,752 |  |  | $ | 12,507 |  |  | $ | 34,648 |  |  | $ | 23,803 |
Segment operating income as a percentage of segment RBR |  | 21.0 | % |  | 16.6 | % |  | 18.7 | % |  | 15.9 | %
Total Huron: |  |  |  |  |  |  |  |
Revenues before reimbursable expenses |  | $ | 465,636 |  |  | $ | 402,505 |  |  | $ | 909,348 |  |  | $ | 798,195 |
Reimbursable expenses |  | 9,406 |  |  | 9,250 |  |  | 17,461 |  |  | 17,701 |
Total revenues |  | $ | 475,042 |  |  | $ | 411,755 |  |  | $ | 926,809 |  |  | $ | 815,896 |
Items not allocated at the segment level: |  |  |  |  |  |  |  |
Unallocated corporate expenses |  | 65,370 |  |  | 54,281 |  |  | 125,400 |  |  | 106,652 |
Other losses (gains) |  | 3,850 |  |  | (71) |  |  | 7,690 |  |  | (71) |
Restructuring charges |  | 562 |  |  | 455 |  |  | 30 |  |  | 1,847 |
Depreciation and amortization |  | 7,040 |  |  | 4,168 |  |  | 13,546 |  |  | 8,345 |
Operating income |  | 50,248 |  |  | 45,654 |  |  | 86,831 |  |  | 78,386 |
Other expense, net |  | (7,340) |  |  | (17,946) |  |  | (16,857) |  |  | (29,226) |
Income before taxes |  | 42,908 |  |  | 27,708 |  |  | 69,974 |  |  | 49,160 |
Income tax expense |  | 11,674 |  |  | 8,278 |  |  | 15,493 |  |  | 5,194 |
Net income |  | $ | 31,234 |  |  | $ | 19,430 |  |  | $ | 54,481 |  |  | $ | 43,966 |
Earnings per share: |  |  |  |  |  |  |  |
Basic |  | $ | 1.93 |  |  | $ | 1.12 |  |  | $ | 3.28 |  |  | $ | 2.50 |
Diluted |  | $ | 1.91 |  |  | $ | 1.09 |  |  | $ | 3.22 |  |  | $ | 2.42 |

30

Table of Contents

Segment and Consolidated Operating Results (in thousands, except per share amounts): |  | Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Other Operating Data: |  |  |  |  |  |  |  |
Number of revenue-generating professionals by segment (at period end): |  |  |  |  |  |  |  |
Healthcare(3) |  | 1,738 |  |  | 1,483 |  |  | 1,738 |  |  | 1,483 |
Education(4) |  | 1,070 |  |  | 1,192 |  |  | 1,070 |  |  | 1,192 |
Commercial (1)(2)(3) |  | 2,527 |  |  | 2,311 |  |  | 2,527 |  |  | 2,311 |
Total (excluding Managed Services) |  | 5,335 |  |  | 4,986 |  |  | 5,335 |  |  | 4,986 |
Managed Services(4)(5) |  | 3,913 |  |  | 1,895 |  |  | 3,913 |  |  | 1,895 |
Total |  | 9,248 |  |  | 6,881 |  |  | 9,248 |  |  | 6,881 |
Revenues before reimbursable expenses by capability: |  |  |  |  |  |  |  |
Consulting and Managed Services(4)(6) |  | $ | 275,921 |  |  | $ | 229,122 |  |  | $ | 547,538 |  |  | $ | 453,043 |
Digital |  | 189,715 |  |  | 173,383 |  |  | 361,810 |  |  | 345,152 |
Total |  | $ | 465,636 |  |  | $ | 402,505 |  |  | $ | 909,348 |  |  | $ | 798,195 |
Number of revenue-generating professionals by capability (at period end): |  |  |  |  |  |  |  |
Consulting(4) |  | 2,198 |  |  | 1,889 |  |  | 2,198 |  |  | 1,889 |
Managed Services(4)(5) |  | 3,913 |  |  | 1,895 |  |  | 3,913 |  |  | 1,895 |
Digital |  | 3,137 |  |  | 3,097 |  |  | 3,137 |  |  | 3,097 |
Total |  | 9,248 |  |  | 6,881 |  |  | 9,248 |  |  | 6,881 |
Utilization rate by capability(7): |  |  |  |  |  |  |  |
Consulting |  | 81.3 | % |  | 77.0 | % |  | 77.8 | % |  | 75.6 | %
Digital |  | 81.8 | % |  | 77.8 | % |  | 78.3 | % |  | 78.0 | %

(1) The majority of our revenue-generating professionals within our Commercial segment can provide services across all of our industries, including healthcare and education, and the related costs of these professionals are allocated to each of the segments.
(2) The increase in the number of revenue-generating professionals within our Commercial segment includes our acquisition of Treliant in the third quarter of 2025. This acquisition added approximately 180 revenue-generating professionals, of which approximately 65 are consultants who work variable schedules as needed by clients.
(3) During the first quarter of 2026, we reclassified the revenue-generating professionals within one of Commercial's Digital offerings to the same Digital offering within Healthcare as these revenue-generating professionals primarily provide services to clients in the healthcare industry. This reclassification had no impact on the total Huron headcount or RBR reported for any period.
The number of revenue-generating professionals within this offering as of December 31, 2024, March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025 was 190, 158, 154, 154, and 145, respectively. The prior period headcount reported by segment in the table above has been revised for consistent presentation.
(4) During the first quarter of 2026, we reclassified one of the offerings within Education's Managed Services capability to Education's Consulting capability. This reclassification had no impact on the total Huron headcount or RBR reported for any period.
The number of revenue-generating professionals within this offering as of December 31, 2024, March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025 was 23, 22, 23, 21 and 21, respectively. The prior period headcount reported by segment and by capability in the table above has been revised for consistent presentation. The prior period Education Managed Services capability headcount in footnote (5) below has been revised for consistent presentation.
RBR generated by this offering during the quarters ended March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025 was $1.8 million, $1.4 million, $1.8 million, and $1.6 million, respectively, and during the years ended December 31, 2024 and 2025 was $7.3 million and $6.6 million, respectively. This reclassification did not impact the total Education Consulting and Managed Services RBR reported for any period, and the prior period Education Managed Services capability RBR in footnote (6) below has been revised for consistent presentation.
(5) We have separately presented the total number of revenue-generating professionals within our Managed Services capabilities of our Healthcare and Education segments. Our Healthcare Managed Services professionals provide revenue cycle, clinical and patient access services from patient scheduling and clinical triage through billing and collections. Our Education Managed Services professionals provide research administration managed services and outsourcing at our education and research-focused clients.
31

Table of Contents
The number of Managed Services professionals within our Healthcare segment was 3,794 and 1,807 as of June 30, 2026 and 2025, respectively. This increase includes our acquisition of RelateCare in the second quarter of 2026, which added approximately 1,100 Managed Services professionals.
The number of Managed Services professionals within our Education segment was 119 and 88 as of June 30, 2026 and 2025, respectively.
(6) Managed Services capability RBR within our Healthcare segment was $34.4 million and $21.0 million for the three months ended June 30, 2026 and 2025, respectively; and $60.5 million and $39.3 million for the six months ended June 30, 2026 and 2025, respectively.
Managed Services capability RBR within our Education segment was $6.9 million and $6.0 million for the three months ended June 30, 2026 and 2025, respectively; and $12.8 million and $11.5 million for the six months ended June 30, 2026 and 2025, respectively.
(7) Utilization rates are presented for our revenue-generating professionals who primarily bill on an hourly basis. We do not present utilization rates for our Managed Services professionals as most of the revenues generated by these employees are not billed on an hourly basis.
32

Table of Contents
Non-GAAP Financial Measures
Reconciliation of Net Income to EBITDA and Adjusted EBITDA

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Revenues before reimbursable expenses | $ | 465,636 |  |  | $ | 402,505 |  |  | $ | 909,348 |  |  | $ | 798,195 |
Reimbursable expenses | 9,406 |  |  | 9,250 |  |  | 17,461 |  |  | 17,701 |
Total revenues | $ | 475,042 |  |  | $ | 411,755 |  |  | $ | 926,809 |  |  | $ | 815,896 |
Net income | $ | 31,234 |  |  | $ | 19,430 |  |  | $ | 54,481 |  |  | $ | 43,966 |
Net income as a percentage of total revenues | 6.6 | % |  | 4.7 | % |  | 5.9 | % |  | 5.4 | %
Add back: |  |  |  |  |  |  |
Income tax expense | 11,674 |  |  | 8,278 |  |  | 15,493 |  |  | 5,194 |
Interest expense, net of interest income | 11,939 |  |  | 9,281 |  |  | 20,830 |  |  | 14,928 |
Depreciation and amortization | 10,408 |  |  | 7,318 |  |  | 20,366 |  |  | 14,467 |
EBITDA | 65,255 |  |  | 44,307 |  |  | 111,170 |  |  | 78,555 |
Add back: |  |  |  |  |  |  |
Restructuring charges | 410 |  |  | 560 |  |  | 1,073 |  |  | 1,898 |
Other losses (gains) | 3,850 |  |  | (71) |  |  | 7,690 |  |  | (71) |
Transaction-related expenses | 1,868 |  |  | 3,590 |  |  | 2,691 |  |  | 4,886 |
Unrealized losses on long-term investments, net | 1,172 |  |  | 11,929 |  |  | 1,172 |  |  | 16,139 |
Gain on sale of business | — |  |  | — |  |  | (303) |  |  | — |
Foreign currency transaction losses (gains), net | 84 |  |  | 264 |  |  | (263) |  |  | 663 |
Adjusted EBITDA | $ | 72,639 |  |  | $ | 60,579 |  |  | $ | 123,230 |  |  | $ | 102,070 |
Adjusted EBITDA as a percentage of revenues before reimbursable expenses | 15.6 | % |  | 15.1 | % |  | 13.6 | % |  | 12.8 | %

Reconciliation of Net Income to Adjusted Net Income and Adjusted Diluted Earnings per Share

| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Net income | $ | 31,234 |  |  | $ | 19,430 |  |  | $ | 54,481 |  |  | $ | 43,966 |
Weighted average shares - diluted | 16,387 |  |  | 17,772 |  |  | 16,902 |  |  | 18,137 |
Diluted earnings per share | $ | 1.91 |  |  | $ | 1.09 |  |  | $ | 3.22 |  |  | $ | 2.42 |
Add back: |  |  |  |  |  |  |
Amortization of intangible assets | 3,938 |  |  | 2,302 |  |  | 7,840 |  |  | 4,338 |
Restructuring charges | 410 |  |  | 560 |  |  | 1,073 |  |  | 1,898 |
Other losses (gains) | 3,850 |  |  | (71) |  |  | 7,690 |  |  | (71) |
Transaction-related expenses | 1,868 |  |  | 3,590 |  |  | 2,691 |  |  | 4,886 |
Unrealized losses on long-term investments, net | 1,172 |  |  | 11,929 |  |  | 1,172 |  |  | 16,139 |
Gain on sale of business | — |  |  | — |  |  | (303) |  |  | — |
Tax effect of adjustments | (2,231) |  |  | (4,075) |  |  | (4,366) |  |  | (6,384) |
Total adjustments, net of tax | 9,007 |  |  | 14,235 |  |  | 15,797 |  |  | 20,806 |
Adjusted net income | $ | 40,241 |  |  | $ | 33,665 |  |  | $ | 70,278 |  |  | $ | 64,772 |
Adjusted weighted average shares - diluted | 16,387 |  |  | 17,772 |  |  | 16,902 |  |  | 18,137 |
Adjusted diluted earnings per share | $ | 2.46 |  |  | $ | 1.89 |  |  | $ | 4.16 |  |  | $ | 3.57 |

33

Table of Contents
Three Months Ended June 30, 2026 Compared to Three Months Ended June 30, 2025
Revenues before Reimbursable Expenses (RBR)
Revenues before reimbursable expenses (RBR) by segment and capability for the three months ended June 30, 2026 and 2025 were as follows:

Revenues before Reimbursable Expenses (in thousands) |  | Three Months Ended June 30, |  | Increase / (Decrease)
| 2026 |  | 2025 |  | $ |  | %
Segment: |  |  |  |  |  |  |  |
Healthcare |  | $ | 232,303 |  |  | $ | 197,822 |  |  | $ | 34,481 |  |  | 17.4 | %
Education |  | 139,375 |  |  | 129,301 |  |  | 10,074 |  |  | 7.8 | %
Commercial |  | 93,958 |  |  | 75,382 |  |  | 18,576 |  |  | 24.6 | %
Total revenues before reimbursable expenses |  | $ | 465,636 |  |  | $ | 402,505 |  |  | $ | 63,131 |  |  | 15.7 | %
Capability: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 275,921 |  |  | $ | 229,122 |  |  | $ | 46,799 |  |  | 20.4 | %
Digital |  | 189,715 |  |  | 173,383 |  |  | 16,332 |  |  | 9.4 | %
Total revenues before reimbursable expenses |  | $ | 465,636 |  |  | $ | 402,505 |  |  | $ | 63,131 |  |  | 15.7 | %

RBR increased $63.1 million, or 15.7%, to $465.6 million for the second quarter of 2026 from $402.5 million for the second quarter of 2025. This growth reflects strength in demand across all three of our operating segments and across both the Consulting and Managed Services and Digital capabilities. The increase includes $19.5 million of incremental RBR from our acquisitions completed since March 31, 2025. Excluding the $19.5 million of incremental RBR from our acquisitions, RBR grew 10.8% organically. Additional information on our RBR by segment follows.
•Healthcare RBR increased $34.5 million, or 17.4%, driven by strengthened demand for our Healthcare managed services, performance improvement, strategy, and financial advisory solutions within our Consulting and Managed Services capability, as well as strengthened demand for our technology and analytics services within our Digital capability; partially offset by a decrease in RBR from our software products within our Digital capability. RBR in the second quarter of 2026 included $10.1 million of incremental RBR from our acquisitions of RelateCare, Eclipse Insights, and AXIOM.
The number of revenue-generating professionals, excluding Managed Services professionals, within our Healthcare segment grew 17.2% to 1,738 as of June 30, 2026, compared to 1,483 as of June 30, 2025. Our acquisition of AXIOM added approximately 40 revenue-generating professionals in 2025. The number of Managed Services revenue-generating professionals within our Healthcare segment grew to 3,794 as of June 30, 2026 from 1,807 as of June 30, 2025. This increase includes our acquisition of RelateCare in the second quarter of 2026, which added approximately 1,100 Managed Services professionals.
•Education RBR increased $10.1 million, or 7.8%, driven by strengthened demand for our technology and analytics services and software products within our Digital capability; partially offset by a decrease in RBR from our education and research consulting solution within our Consulting and Managed Services capability.
The number of revenue-generating professionals within our Education segment, excluding Managed Services professionals, decreased 10.2% to 1,070 as of June 30, 2026, compared to 1,192 as of June 30, 2025.
•Commercial RBR increased $18.6 million, or 24.6%, which reflects $9.2 million of incremental RBR from our acquisitions of Treliant and WP&C and strengthened demand for our financial advisory solution within our Consulting and Managed Services capability; partially offset by a decrease in RBR from our technology and analytics services within our Digital capability.
The number of revenue-generating professionals within our Commercial segment, the majority of which provide services across all of our industries, grew 9.3% to 2,527 as of June 30, 2026, compared to 2,311 as of June 30, 2025. Our acquisitions of Treliant and WP&C in 2025 added approximately 210 revenue-generating professionals.
34

Table of Contents
Operating Expenses
Operating expenses for the second quarter of 2026 increased $58.7 million, or 16.0%, over the second quarter of 2025.
Operating expenses and operating expenses as a percentage of revenues before reimbursable expenses (RBR) were as follows:

Operating Expenses (in thousands, except amounts as a percentage of revenues before reimbursable expenses) |  | Three Months Ended June 30, |  | Increase / (Decrease)
| 2026 |  | 2025 |
Direct costs |  | $ | 311,187 |  |  | 66.8% |  | $ | 269,028 |  |  | 66.8% |  | $ | 42,159 |
Reimbursable expenses |  | 9,406 |  |  | 2.0% |  | 9,250 |  |  | 2.3% |  | 156 |
Selling, general and administrative expenses |  | 89,793 |  |  | 19.3% |  | 80,217 |  |  | 19.9% |  | 9,576 |
Other losses (gains) |  | 3,850 |  |  | 0.8% |  | (71) |  |  | —% |  | 3,921 |
Restructuring charges |  | 410 |  |  | 0.1% |  | 560 |  |  | 0.1% |  | (150) |
Depreciation and amortization |  | 10,148 |  |  | 2.2% |  | 7,117 |  |  | 1.8% |  | 3,031 |
Total operating expenses |  | $ | 424,794 |  |  | 91.2% |  | $ | 366,101 |  |  | 91.0% |  | $ | 58,693 |

Direct Costs
Direct costs increased $42.2 million, or 15.7%, to $311.2 million for the second quarter of 2026 from $269.0 million for the second quarter of 2025. The $42.2 million increase primarily related to a $41.5 million increase in compensation costs for our revenue-generating professionals. The increase in compensation costs reflects our investment to grow our talented team to meet increased market demand and is primarily attributable to a $30.9 million increase in salaries and related expenses, driven by recent acquisitions, hiring to support the overall increase in demand for our services and annual salary increases that went into effect in the first quarter of 2026; a $9.0 million increase in performance bonus expense; and a $1.1 million increase in share-based compensation expense. Directs costs as a percentage of RBR was 66.8% for both the second quarter of 2026 and 2025.
Reimbursable Expenses
Reimbursable expenses are billed to clients at cost and primarily relate to travel and out-of-pocket expenses incurred in connection with client engagements. These expenses are also included in total revenues. We manage our business on the basis of revenues before reimbursable expenses (RBR), which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that are also included as a component of operating expenses.
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased by $9.6 million, or 11.9%, to $89.8 million in the second quarter of 2026 from $80.2 million in the second quarter of 2025. The $9.6 million increase related to a $7.1 million increase in compensation costs for our support personnel and a $2.4 million increase in non-payroll costs. The $7.1 million increase in compensation costs for our support personnel was primarily driven by a $2.4 million increase in deferred compensation expense attributable to the change in market value of our deferred compensation liability, a $2.4 million increase in salaries and related expenses, a $1.4 million increase in performance bonus expense, and a $0.9 million increase in share-based compensation. The increase in deferred compensation expense is offset by an increase in the gain recognized for the change in the market value of investments that are used to fund our deferred compensation liability and recognized in other income (expense), net. The $2.4 million increase in non-payroll costs was primarily driven by a $2.1 million increase in software and data hosting expenses. As a percentage of RBR, selling, general and administrative expenses decreased to 19.3% during the second quarter of 2026, compared to 19.9% during the second quarter of 2025, which was primarily due to revenue growth that outpaced the increase in salaries and related expenses for our support personnel.
Other Losses (Gains)
Other losses (gains) totaled a loss of $3.9 million in the second quarter of 2026 compared to a gain of $0.1 million in the second quarter of 2025. The $3.9 million of other losses in the second quarter of 2026 consisted of remeasurement losses to increase the fair value of our contingent consideration liabilities related to business combinations. The $0.1 million of other gains in the second quarter of 2025 consisted of a remeasurement gain to decrease the fair value of a contingent consideration liability related to a business combination.
See Note 11 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on the fair value of contingent consideration liabilities.
35

Table of Contents
Restructuring Charges
Restructuring charges for the second quarter of 2026 were $0.4 million, compared to $0.6 million for the second quarter of 2025. The $0.4 million of restructuring charges recognized in the second quarter of 2026 included $0.7 million of rent and related expenses, net of sublease income, for our previously vacated office spaces, partially offset by a $0.2 million non-cash gain on lease modification on our office space in Hillsboro, Oregon. The $0.6 million of restructuring charges recognized in the second quarter of 2025 primarily consisted of rent and related expenses, net of sublease income, for our previously vacated office spaces.
Depreciation and Amortization
Depreciation and amortization expense increased $3.0 million, or 42.6%, to $10.1 million in the second quarter of 2026, compared to $7.1 million in the second quarter of 2025. The $3.0 million increase in depreciation and amortization expense was primarily attributable to increases in amortization of intangible assets acquired in business acquisitions and internally developed software.
Operating Income
Operating income increased $4.6 million, or 10.1%, to $50.2 million in the second quarter of 2026 from $45.7 million in the second quarter of 2025. Operating margin, which is defined as operating income expressed as a percentage of revenues before reimbursable expenses (RBR) was 10.8% for the three months ended June 30, 2026, compared to 11.3% for the three months ended June 30, 2025.
Operating income and operating margin for each of our segments as well as unallocated corporate expenses were as follows:

Segment Operating Income (in thousands, except operating margin percentages) |  | Three Months Ended June 30, |  | Increase / (Decrease)
| 2026 |  | 2025 |
Healthcare |  | $ | 69,902 |  |  | 30.1% |  | $ | 59,651 |  |  | 30.2% |  | $ | 10,251 |
Education |  | $ | 37,416 |  |  | 26.8% |  | $ | 32,329 |  |  | 25.0% |  | $ | 5,087 |
Commercial |  | $ | 19,752 |  |  | 21.0% |  | $ | 12,507 |  |  | 16.6% |  | $ | 7,245 |
Unallocated Corporate Expenses (in thousands) |  |  |  |  |  |  |  |  |  |
Unallocated corporate expenses |  | $ | 65,370 |  |  |  |  | $ | 54,281 |  |  |  |  | $ | 11,089 |

•Healthcare operating income increased $10.3 million, or 17.2%, primarily due to the increase in RBR, as well as a decrease in salaries and related expenses for our support personnel; partially offset by increases in compensation costs for our revenue-generating professionals and contractor expenses. The increase in compensation costs for our revenue-generating professionals was primarily due to an increase in headcount, partially driven by our acquisition of RelateCare, and annual salary increases that went into effect in the first quarter of 2026, as well as an increase in performance bonus expense. Healthcare operating margin remained relatively flat at 30.1% in the second quarter of 2026, compared to 30.2% in the second quarter of 2025.
•Education operating income increased $5.1 million, or 15.7%, primarily due to the increase in RBR; partially offset by an increase in compensation costs for our revenue-generating professionals. The increase in compensation costs for our revenue-generating professionals was primarily driven by an increase in performance bonus expense as well as annual salary increases that went into effect in the first quarter of 2026. Education operating margin increased to 26.8% from 25.0% primarily driven by revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals and a decrease in project costs; partially offset by the increases in performance bonus expense, amortization of internally developed software, and share-based compensation expense for our revenue-generating professionals, as percentages of RBR.
•Commercial operating income increased $7.2 million, or 57.9%, primarily due to the increase in RBR, as well a decrease in contractor expenses; partially offset by an increase in compensation costs for our revenue-generating professionals. The increase in compensation costs for our revenue-generating professionals was primarily due to an increase in headcount, driven by our acquisitions of Treliant and WP&C, annual salary increases that went into effect in the first quarter of 2026, and increases in performance bonus expense and share-based compensation expense. Commercial operating margin increased to 21.0% from 16.6% primarily driven by decreases in contractor expenses and salaries and related expenses for our support personnel, as well as revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals; partially offset by increases in performance bonus expense and share-based compensation expense for our revenue-generating professionals, as percentages of RBR.
•Unallocated corporate expenses increased $11.1 million, or 20.4%, primarily due to increases in compensation costs for our support personnel and software and data hosting expenses. The increase in compensation costs for our support personnel was primarily driven by an increase in headcount, annual salary increases that went into effect in the first quarter of 2026 and an increase in deferred compensation expense attributable to the change in the market value of our deferred compensation liability, and an increase in performance bonus expense.
36

Table of Contents
Other Income (Expense), Net
Interest expense, net of interest income increased $2.7 million to $11.9 million in the second quarter of 2026 from $9.3 million in the second quarter of 2025, which was primarily attributable to higher levels of borrowing under our senior secured credit facility during the second quarter of 2026 compared to the second quarter of 2025. See “Liquidity and Capital Resources” below and Note 8 “Financing Arrangements” within the notes to our consolidated financial statements for additional information about our senior secured credit facility.
Other income (expense), net totaled income of $4.6 million in the second quarter of 2026, compared to expense of $8.7 million in the second quarter of 2025. In the second quarter of 2026, we recognized a $5.8 million gain on the market value of our investments that are used to fund our deferred compensation liability and a $1.1 million gain resulting from a reduction to the credit allowance recognized on our convertible debt investment in a third-party. These gains were partially offset by a non-cash impairment charge of $2.2 million on our equity investment in a hospital-at-home company and $0.1 million of foreign currency transaction losses. In the second quarter of 2025, we recognized a pre-tax $11.1 million non-cash credit-related impairment charge related to our convertible debt investment in a third-party, a non-cash impairment charge of $0.8 million on our equity investment in a hospital-at-home company, and $0.2 million of foreign currency transaction losses. These losses were offset by a $3.5 million gain on the market value of our investments that are used to fund our deferred compensation liability. The change in the market value of our investments that are used to fund our deferred compensation liability are offset with deferred compensation expense which is recognized as a component of selling, general and administrative expenses on our consolidated statements of operations.
See Note 10 “Derivative Instruments and Hedging Activity” within the notes to our consolidated financial statements for additional information on our foreign exchange forward contracts and Note 11 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on our convertible debt and equity investments.
Income Tax Expense
For the three months ended June 30, 2026, our effective tax rate was 27.2% as we recognized income tax expense of $11.7 million on income of $42.9 million. The effective tax rate of 27.2% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to certain nondeductible expense items and the inability to recognize tax benefits related to certain foreign and capital losses, partially offset by a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability.
For the three months ended June 30, 2025, our effective tax rate was 29.9% as we recognized income tax expense of $8.3 million on income of $27.7 million. The effective tax rate of 29.9% was less favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to the establishment of a valuation allowance for a deferred tax asset recorded as the result of the capital loss on our investment in a hospital-at-home company as well as certain nondeductible expense items, partially offset by a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability.
Net Income and Earnings per Share
Net income increased $11.8 million, or 60.8%, to $31.2 million for the three months ended June 30, 2026 from $19.4 million for the same period last year. The second quarter of 2025 includes the $8.2 million non-cash credit-related impairment charge, net of tax, related to our convertible debt investment in a third-party. Diluted earnings per share for the second quarter of 2026 increased to $1.91 from $1.09 for the second quarter of 2025 driven by the increase in net income as well as a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan. The non-cash credit-related impairment charge on our convertible debt investment recognized in the second quarter of 2025 had an unfavorable $0.46 impact on diluted EPS in the prior year period.
EBITDA and Adjusted EBITDA
EBITDA increased $20.9 million, or 47.3%, to $65.3 million for the second quarter of 2026 from $44.3 million for the second quarter of 2025. The increase in EBITDA was primarily attributable to the increase in segment operating income for all three of our segments, excluding segment depreciation and amortization, and the absence of the prior year $11.1 million non-cash credit-related impairment charge recognized in the second quarter of 2025 related to our convertible debt investment in a third-party; partially offset by the increase in unallocated corporate expenses, excluding the impact of the change in the market value of our deferred compensation liability, and the $3.9 million of remeasurement losses to increase the fair value of our contingent consideration liabilities related to business combinations recognized in the first quarter of 2026.
Adjusted EBITDA increased $12.1 million, or 19.9%, to $72.6 million in the second quarter of 2026 from $60.6 million in the second quarter of 2025. The increase in adjusted EBITDA was primarily attributable to the increase in segment operating income for all three of our segments, excluding segment depreciation and amortization and segment restructuring charges; partially offset by the increase in unallocated corporate expenses, excluding the impact of the change in the market value of our deferred compensation liability and transaction-related expenses.
37

Table of Contents
Adjusted Net Income and Adjusted Earnings per Share
Adjusted net income increased $6.6 million, or 19.5%, to $40.2 million in the second quarter of 2026, compared to $33.7 million in the second quarter of 2025. As a result of the increase in adjusted net income as well as a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan, the adjusted diluted earnings per share increased to $2.46 for the second quarter of 2026 compared to $1.89 for the second quarter of 2025.
Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025
Revenues before Reimbursable Expenses (RBR)
Revenues before reimbursable expenses (RBR) by segment and capability for the six months ended June 30, 2026 and 2025 were as follows:

Revenues before Reimbursable Expenses (in thousands) |  | Six Months Ended June 30, |  | Increase / (Decrease)
| 2026 |  | 2025 |  | $ |  | %
Segment: |  |  |  |  |  |  |  |
Healthcare |  | $ | 457,504 |  |  | $ | 396,312 |  |  | $ | 61,192 |  |  | 15.4 | %
Education |  | 266,843 |  |  | 252,049 |  |  | 14,794 |  |  | 5.9 | %
Commercial |  | 185,001 |  |  | 149,834 |  |  | 35,167 |  |  | 23.5 | %
Total revenues before reimbursable expenses |  | $ | 909,348 |  |  | $ | 798,195 |  |  | $ | 111,153 |  |  | 13.9 | %
Capability: |  |  |  |  |  |  |  |
Consulting and Managed Services |  | $ | 547,538 |  |  | $ | 453,043 |  |  | $ | 94,495 |  |  | 20.9 | %
Digital |  | 361,810 |  |  | 345,152 |  |  | 16,658 |  |  | 4.8 | %
Total revenues before reimbursable expenses |  | $ | 909,348 |  |  | $ | 798,195 |  |  | $ | 111,153 |  |  | 13.9 | %

RBR increased $111.2 million, or 13.9%, to $909.3 million for the first six months of 2026 from $798.2 million for the first six months of 2025. This growth reflects strength in demand across all three of our operating segments and across both the Consulting and Managed Services and Digital capabilities. The increase includes $38.7 million of incremental RBR from our acquisitions completed since December 31, 2024. Excluding the $38.7 million of incremental RBR from our acquisitions, RBR grew 9.1% organically. Additional information on our RBR by segment follows.
•Healthcare RBR increased $61.2 million, or 15.4%, driven by strengthened demand for our performance improvement, Healthcare managed services, financial advisory, and strategy solutions within our Consulting and Managed Services capability and technology and analytics services within our Digital capability; partially offset by a decrease in RBR from our software products within our Digital capability. RBR in the first six months of 2026 included $17.4 million of incremental RBR from our acquisitions of Eclipse Insights, RelateCare, and AXIOM.
The number of revenue-generating professionals, excluding Managed Services professionals, within our Healthcare segment grew 17.2% to 1,738 as of June 30, 2026, compared to 1,483 as of June 30, 2025. Our acquisition of AXIOM added approximately 40 revenue-generating professionals in 2025. The number of Managed Services revenue-generating professionals within our Healthcare segment grew to 3,794 as of June 30, 2026 from 1,807 as of June 30, 2025. This increase includes our acquisition of RelateCare in the second quarter of 2026, which added approximately 1,100 Managed Services professionals.
•Education RBR increased $14.8 million, or 5.9%, driven by strengthened demand for our technology and analytics services and software products within our Digital capability; partially offset by a decrease in RBR from our education and research consulting solution within our Consulting and Managed Services capability. RBR in the first six months of 2026 included $1.0 million of incremental RBR from our acquisitions of Advancement Resources and Halpin.
The number of revenue-generating professionals within our Education segment, excluding Managed Services professionals, decreased 10.2% to 1,070 as of June 30, 2026, compared to 1,192 as of June 30, 2025.
•Commercial RBR increased $35.2 million, or 23.5%, which reflects $20.2 million of incremental RBR from our acquisitions of WP&C and Treliant and strengthened demand for our financial advisory and strategy solutions within our Consulting and Managed Services capability; partially offset by a decrease in RBR from our technology and analytics services within our Digital capability.
The number of revenue-generating professionals within our Commercial segment, the majority of which provide services across all of our industries, grew 9.3% to 2,527 as of June 30, 2026, compared to 2,311 as of June 30, 2025. Our acquisitions of Treliant and WP&C in 2025 added approximately 210 revenue-generating professionals.
38

Table of Contents
Operating Expenses
Operating expenses for the first six months of 2026 increased $102.5 million, or 13.9%, over the first six months of 2025.
Operating expenses and operating expenses as a percentage of revenues before reimbursable expenses were as follows:

Operating Expenses (in thousands, except amounts as a percentage of revenues before reimbursable expenses) |  | Six Months Ended June 30, |  | Increase / (Decrease)
| 2026 |  | 2025 |
Direct costs |  | $ | 619,381 |  |  | 68.1% |  | $ | 547,071 |  |  | 68.5% |  | $ | 72,310 |
Reimbursable expenses |  | 17,461 |  |  | 1.9% |  | 17,695 |  |  | 2.2% |  | (234) |
Selling, general and administrative expenses |  | 174,504 |  |  | 19.2% |  | 156,851 |  |  | 19.7% |  | 17,653 |
Other losses (gains) |  | 7,690 |  |  | 0.8% |  | (71) |  |  | —% |  | 7,761 |
Restructuring charges |  | 1,073 |  |  | 0.1% |  | 1,898 |  |  | 0.2% |  | (825) |
Depreciation and amortization |  | 19,869 |  |  | 2.2% |  | 14,066 |  |  | 1.8% |  | 5,803 |
Total operating expenses |  | $ | 839,978 |  |  | 92.4% |  | $ | 737,510 |  |  | 92.4% |  | $ | 102,468 |

Direct Costs
Direct costs increased $72.3 million, or 13.2%, to $619.4 million for the first six months of 2026 from $547.1 million for the first six months of 2025. The $72.3 million increase primarily related to a $71.5 million increase in compensation costs for our revenue-generating professionals and a $2.2 million increase in technology costs; partially offset by a $1.9 million decrease in contractor expenses. The increase in compensation costs reflects our investment to grow our talented team to meet increased market demand and is primarily attributable to a $60.5 million increase in salaries and related expenses, driven by recent acquisitions, hiring to support the overall increase in demand for our services and annual salary increases that went into effect in the first quarter of 2026, and a $10.7 million increase in performance bonus expense. As a percentage of revenues before reimbursable expenses, direct costs decreased to 68.1% during the first six months of 2026, compared to 68.5% during the first six months of 2025, primarily driven by the decrease in contractor expenses.
Reimbursable Expenses
Reimbursable expenses are billed to clients at cost and primarily relate to travel and out-of-pocket expenses incurred in connection with client engagements. These expenses are also included in total revenues. We manage our business on the basis of revenues before reimbursable expenses (RBR), which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that are also included as a component of operating expenses.
Selling, General and Administrative Expenses
Selling, general and administrative expenses increased by $17.7 million, or 11.3%, to $174.5 million in the first six months of 2026 from $156.9 million in the first six months of 2025. The $17.7 million increase related to an $8.8 million increase in compensation costs for our support personnel and an $8.7 million increase in non-payroll costs. The $8.8 million increase in compensation costs for our support personnel was primarily driven by a $3.8 million increase in salaries and related expenses, a $2.2 million increase in deferred compensation expense attributable to the change in market value of our deferred compensation liability, a $1.9 million increase in share-based compensation expense, and a $1.1 million increase in performance bonus expense. The increase in deferred compensation expense is offset by an increase in the gain recognized for the change in the market value of investments that are used to fund our deferred compensation liability and recognized in other income (expense), net. The $8.7 million increase in non-payroll costs was primarily driven by a $4.5 million increase in software and data hosting expenses, a $1.5 million increase in practice administration and meetings expenses, a $1.1 million increase in third-party professional fees, and a $1.0 million increase in facilities expenses. As a percentage of revenues before reimbursable expenses, selling, general and administrative expenses decreased to 19.2% during the first six months of 2026, compared to 19.7% during the first six months of 2025, which was primarily due to revenue growth that outpaced the increase in compensation costs for our support personnel.
Other Losses (Gains)
Other losses (gains) totaled a loss of $7.7 million in the first six months of 2026 compared to a gain of $0.1 million in the first six months of 2025. The $7.7 million of other losses in the first six months of 2026 consisted of remeasurement losses to increase the fair value of our contingent consideration liabilities related to business combinations. The $0.1 million of other gains in the first six months of 2025 consisted of a remeasurement gain to decrease the fair value of a contingent consideration liability related to a business combination.
See Note 11 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on the fair value of contingent consideration liabilities.
39

Table of Contents
Restructuring Charges
Restructuring charges for the first six months of 2026 were $1.1 million, compared to $1.9 million for the first six months of 2025. The $1.1 million of restructuring charges recognized in the first six months of 2026 included $3.2 million of severance-related expenses and $1.7 million of rent and related expenses, net of sublease income, for our previously vacated office spaces, largely offset by $4.0 million of non-cash gains on lease modifications. In the first quarter of 2026, we entered into the Seventh Amendment to the office lease agreement for our principal executive offices in Chicago, Illinois, which, among other items, provides for the early termination of the lease with respect to certain leased spaces previously vacated. As a result of this modification, we recognized a $3.8 million non-cash gain on lease modification. In the second quarter of 2026, we recorded a $0.2 million non-cash gain on lease modification on our office space in Hillsboro, Oregon. See Note 14 “Commitments, Contingencies and Guarantees” within the notes to our consolidated financial statements for additional information on the Seventh Amendment to the Chicago, Illinois office lease.
The $1.9 million of restructuring charges recognized in the first six months of 2025 primarily consisted of $1.0 million of rent and related expenses, net of sublease income, for our previously vacated office spaces and a $0.7 million non-cash lease impairment charge driven by updated sublease assumptions for a previously vacated office space.
Depreciation and Amortization
Depreciation and amortization expense increased $5.8 million, or 41.3%, to $19.9 million for the first six months of 2026, compared to $14.1 million for the first six months of 2025. The $5.8 million increase in depreciation and amortization expense was primarily attributable to increases in amortization of intangible assets acquired in business acquisitions and internally developed software.
Operating Income
Operating income increased $8.4 million, or 10.8%, to $86.8 million in the first six months of 2026 from $78.4 million in the first six months of 2025. Operating margin, which is defined as operating income expressed as a percentage of revenues before reimbursable expenses (RBR) was 9.5% for the first six months of 2026, compared to 9.8% for the first six months of 2025.
Operating income and operating margin for each of our segments as well as unallocated corporate expenses were as follows:

Segment Operating Income (in thousands, except operating margin percentages) |  | Six Months Ended June 30, |  | Increase / (Decrease)
| 2026 |  | 2025 |
Healthcare |  | $ | 133,855 |  |  | 29.3% |  | $ | 115,967 |  |  | 29.3% |  | $ | 17,888 |
Education |  | $ | 64,994 |  |  | 24.4% |  | $ | 55,389 |  |  | 22.0% |  | $ | 9,605 |
Commercial |  | $ | 34,648 |  |  | 18.7% |  | $ | 23,803 |  |  | 15.9% |  | $ | 10,845 |
Unallocated Corporate Expenses (in thousands) |  |  |  |  |  |  |  |  |  |
Unallocated corporate expenses |  | $ | 125,400 |  |  |  |  | $ | 106,652 |  |  |  |  | $ | 18,748 |

•Healthcare operating income increased $17.9 million, or 15.4%, primarily due to the increase in RBR, as well as a decrease in salaries and related expenses for our support personnel; partially offset by increases in compensation costs for our revenue-generating professionals and practice administration and meetings expenses. The increase in compensation costs for our revenue-generating professionals was primarily due to an increase in headcount, partially driven by our acquisition of RelateCare, and annual salary increases that went into effect in the first quarter of 2026, as well as an increase in performance bonus expense. Healthcare operating margin was 29.3% for both the first six months of 2026 and 2025.
•Education operating income increased $9.6 million, or 17.3%, primarily due to the increase in RBR, as well as decreases in practice administration and meeting expenses and salaries and related expenses for our support personnel; partially offset by increases in compensation costs for our revenue-generating professionals, technology costs, and amortization of internally developed software. The increase in compensation costs for our revenue-generating professionals was primarily driven by annual salary increases that went into effect in the first quarter of 2026, as well as an increase in performance bonus expense. Education operating margin increased to 24.4% from 22.0% primarily due to revenue growth that outpaced the increase in compensation costs for our revenue-generating professionals and the decrease in practice administration and meeting expenses.
•Commercial operating income increased $10.8 million, or 45.6%, primarily due to the increase in RBR, as well as a decrease in contractor expenses; partially offset by an increase in compensation costs for our revenue-generating professionals. The increase in compensation costs for our revenue-generating professionals was primarily due to an increase in headcount, driven by our acquisitions of Treliant and WP&C, and annual salary increases that went into effect in the first quarter of 2026, as well as increases in performance bonus expense and share-based compensation expense. Commercial operating margin increased to 18.7% from 15.9% primarily due to the decrease in contractor expenses.
40

Table of Contents
•Unallocated corporate expenses increased $18.7 million, or 17.6%, primarily due to increases in compensation costs for our support personnel and software and data hosting expenses. The increases in compensation costs for our support personnel was primarily driven by an increase in headcount, annual salary increases that went into effect in the first quarter of 2026 and an increase in deferred compensation expense attributable to the change in the market value of our deferred compensation liability, as well as increases in share-based compensation expense and performance bonus expense.
Other Income (Expense), Net
Interest expense, net of interest income increased $5.9 million to $20.8 million in the first six months of 2026 from $14.9 million in the first six months of 2025, which was primarily attributable to higher levels of borrowing under our senior secured credit facility during the first six months of 2026 compared to the first six months of 2025. See “Liquidity and Capital Resources” below and Note 8 “Financing Arrangements” within the notes to our consolidated financial statements for additional information about our senior secured credit facility.
Other income (expense), net totaled income of $4.0 million in the first six months of 2026, compared to expense of $14.3 million in the first six months of 2025. In the first six months of 2026, we recognized a $4.5 million gain on the market value of our investments that are used to fund our deferred compensation liability, a $1.1 million gain resulting from a reduction to the credit allowance recognized on our convertible debt investment in a third-party, and $0.3 million of foreign currency transaction gains. These gains were partially offset by a non-cash impairment charge of $2.2 million on our equity investment in a hospital-at-home company. In the first six months of 2025, we recognized a pre-tax $11.1 million non-cash credit-related impairment charge related to our convertible debt investment in a third-party, non-cash impairment charges of $5.0 million on our equity investment in a hospital-at-home company and $0.6 million of foreign currency transaction losses; partially offset by a $2.5 million gain recognized on the market value of our investments that are used to fund our deferred compensation liability. The change in the market value of our investments that are used to fund our deferred compensation liability are offset with deferred compensation expense which is recognized as a component of selling, general and administrative expenses on our consolidated statements of operations.
See Note 10 “Derivative Instruments and Hedging Activity” within the notes to our consolidated financial statements for additional information on our foreign exchange forward contracts and Note 11 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on our convertible debt and equity investments.
Income Tax Expense
For the six months ended June 30, 2026, our effective tax rate was 22.1% as we recognized income tax expense of $15.5 million on income of $70.0 million. The effective tax rate of 22.1% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2026 and a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability. These favorable items were partially offset by certain nondeductible expense items and the inability to recognize tax benefits related to certain foreign and capital losses.
For the six months ended June 30, 2025, our effective tax rate was 10.6% as we recognized income tax expense of $5.2 million on income of $49.2 million. The effective tax rate of 10.6% was more favorable than the statutory rate, inclusive of state income taxes, of 26.0%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2025. This favorable item was partially offset by the establishment of a valuation allowance for a deferred tax asset recorded as the result of the capital loss on our investment in a hospital-at-home company and certain nondeductible expenses.
Net Income and Earnings per Share
Net income increased $10.5 million, or 23.9%, to $54.5 million for the six months ended June 30, 2026 from $44.0 million for the same period last year. The second quarter of 2025 includes the $8.2 million non-cash credit-related impairment charge, net of tax, related to our convertible debt investment in a third-party. Diluted earnings per share for the six months ended June 30, 2026 increased to $3.22 compared to $2.42 for the six months ended June 30, 2025; driven by the increase in net income as well as a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan. The non-cash credit-related impairment charge on our convertible debt investment had an unfavorable $0.45 impact on diluted EPS during the first six months of 2025.
EBITDA and Adjusted EBITDA
EBITDA increased $32.6 million, or 41.5%, to $111.2 million for the six months ended June 30, 2026 from $78.6 million for the six months ended June 30, 2025. The increase in EBITDA was primarily attributable to the increase in segment operating income for all three of our segments, excluding segment depreciation and amortization, and the absences of the prior year $11.1 million non-cash credit-related impairment charge related to our convertible debt investment in a third-party and the prior year $5.0 million of non-cash impairment charges recognized on our equity investment in a hospital-at-home company; partially offset by the increase in unallocated corporate expenses, excluding the impact of the change in the market value of our deferred compensation liability, and the $7.7 million of remeasurement losses to increase the fair value of our contingent consideration liabilities related to business combinations recognized in the first quarter of 2026.
41

Table of Contents
Adjusted EBITDA increased $21.2 million, or 20.7%, to $123.2 million in the first six months of 2026 from $102.1 million in the first six months of 2025. The increase in adjusted EBITDA was primarily attributable to the increases in segment operating income for all three of our segments, excluding segment depreciation and amortization and segment restructuring charges; partially offset by the increase in unallocated corporate expenses, excluding the impacts of the change in the market value of our deferred compensation liability and transaction-related expenses.
Adjusted Net Income and Adjusted Earnings per Share
Adjusted net income increased $5.5 million, or 8.5%, to $70.3 million in the first six months of 2026 compared to $64.8 million in the first six months of 2025. As a result of the increase in adjusted net income as well as a reduction in diluted shares outstanding resulting from share repurchases made under our share repurchase plan, adjusted diluted earnings per share increased to $4.16 for the six months ended June 30, 2026, compared to $3.57 for the six months ended June 30, 2025.
LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents were $31.2 million and $24.5 million at June 30, 2026 and December 31, 2025, respectively. As of June 30, 2026, our primary sources of liquidity are cash on hand, cash flows from our U.S. operations, and borrowing capacity available under our credit facility.

|  | Six Months Ended June 30,
Cash Flows (in thousands): |  | 2026 |  | 2025
Net cash used in operating activities |  | $ | (41,702) |  |  | $ | (26,780) |
Net cash used in investing activities |  | (47,730) |  |  | (70,080) |
Net cash provided by financing activities |  | 96,297 |  |  | 135,804 |
Effect of exchange rate changes on cash |  | (145) |  |  | 156 |
Net increase in cash and cash equivalents |  | $ | 6,720 |  |  | $ | 39,100 |

Operating Activities
Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, operating lease obligations and deferred revenues. The volume of services rendered and the related billings and timing of collections on those billings, as well as payments of our accounts payable and salaries, bonuses, and related benefits to employees affect these account balances. Our purchase obligations primarily consist of payments for software and other information technology products to support our business and corporate infrastructure.
Net cash used in operating activities increased by $14.9 million to $41.7 million for the six months ended June 30, 2026 from $26.8 million for the six months ended June 30, 2025. The increase in net cash used in operating activities was primarily related to increases in payments for salaries and related expenses for our revenue-generating professionals, selling, general and administrative expenses, and the amount paid for annual performance bonuses in the first quarter of 2026 compared to the first quarter of 2025; partially offset by an increase in cash collections in the first six months of 2026 compared to the first six months of 2025.
Investing Activities
Our investing activities primarily consist of purchases of complementary businesses; purchases of property and equipment, primarily related to computers and related equipment for our employees and leasehold improvements and furniture and fixtures for office spaces; payments related to internally developed cloud-based software sold to our clients; and investments. Our investments include a convertible note investment in Shorelight Holdings, LLC, an equity investment in a hospital-at-home company, and investments in life insurance policies that are used to fund our deferred compensation liability.
Net cash used in investing activities for the six months ended June 30, 2026 was $47.7 million, which primarily consisted of $27.8 million for the purchases of businesses; $10.9 million for purchases of property and equipment, primarily related to purchases of computers and related equipment and leasehold improvements for certain office spaces; $10.1 million for payments related to internally developed software to advance our Education and Healthcare software products; and $2.0 million for a payment related to the origination of a note receivable. These uses of cash for investing activities were partially offset by $2.3 million of cash received to settle an outstanding promissory note from the 2024 divestiture of our Studer Education practice.
Net cash used in investing activities for the six months ended June 30, 2025 was $70.1 million, which primarily consisted of $53.1 million for the purchases of businesses; $10.9 million for payments related to internally developed software to advance our Education and Healthcare software products; $3.9 million for purchases of property and equipment, primarily related to purchases of computers and related equipment and leasehold improvements for certain office spaces; and $2.3 million for contributions to our life insurance policies.
42

Table of Contents
We estimate that cash utilized for purchases of property and equipment and software development in 2026 will total approximately $35 million to $40 million; primarily consisting of software development costs, information technology-related equipment to support our corporate infrastructure, and leasehold improvements and furniture and fixtures for certain office spaces.
Financing Activities
Our financing activities primarily consist of borrowings and repayments under our senior secured credit facility, share repurchases, shares redeemed for employee tax withholdings upon vesting of share-based compensation, and payments for contingent consideration liabilities related to business acquisitions. See “Financing Arrangements” below for additional information on our senior secured credit facility.
Net cash provided by financing activities for the six months ended June 30, 2026 was $96.3 million. The net borrowings of $323.0 million during the first six months of 2026 were primarily used to fund our operations, including our annual performance bonus payments in the first quarter of 2026, share repurchases, and the business acquisition in the second quarter of 2026. Additionally, during the first six months of 2026, we paid $206.7 million for the settlement of share repurchases and we reacquired $20.8 million of common stock as a result of tax withholdings upon vesting of share-based compensation. These uses of cash for financing activities were partially offset by $0.8 million of cash received from stock option exercises in the first six months of 2026.
Net cash provided by financing activities for the six months ended June 30, 2025 was $135.8 million. The net borrowings of $300.1 million during the first six months of 2025 were primarily used to fund our operations, including our annual performance bonus payments in the first quarter of 2025, and our programmatic business acquisitions. Additionally, during the first six months of 2025, we paid $134.4 million for the settlement of share repurchases and we reacquired $32.5 million of common stock as a result of tax withholdings upon vesting of share-based compensation. These uses of cash for financing activities were partially offset by $2.6 million of cash received from stock option exercises in the first six months of 2025.
Share Repurchase Program
In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. The share repurchase program has been subsequently extended and increased, most recently in the first quarter of 2026. The current authorization extends the share repurchase program through December 31, 2026 with a repurchase amount of $900 million, of which $92.0 million remains available as of June 30, 2026. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements.
Financing Arrangements
At June 30, 2026, we had $834.0 million outstanding under our senior secured credit agreement, as discussed below.
The company has a $700 million Revolver and a $400 million Term Loan, subject to the terms of the Fourth Amended and Restated Credit Agreement dated as of July 30, 2025 (the “Amended Credit Agreement”), both of which mature on July 30, 2030. The Term Loan is subject to scheduled quarterly amortization payments of $5.0 million which began September 30, 2025 and continue through the maturity date of July 30, 2030, at which time the outstanding principal balance and all accrued interest will be due.
Fees and interest on borrowings under the Amended Credit Agreement vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, these borrowings will bear interest at one, three or six month Term SOFR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.250% per annum and 1.875% per annum, in the case of Term SOFR borrowings, or between 0.250% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.
Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including upon an Event of Default (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.
The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.25 to 1.00 upon the occurrence of a Qualified Acquisition (as defined in the Amended Credit Agreement), and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.00 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At June 30, 2026 and December 31, 2025, we were in compliance with these financial
43

Table of Contents
covenants. Our Consolidated Leverage Ratio as of June 30, 2026 was 2.82 to 1.00, compared to 1.93 to 1.00 as of December 31, 2025. Our Consolidated Interest Coverage Ratio as of June 30, 2026 was 7.48 to 1.00, compared to 8.12 to 1.00 as of December 31, 2025.
The Amended Credit Agreement contains restricted payment provisions, including a potential limit on the amount of dividends we may pay. Pursuant to the terms of the Amended Credit Agreement, if our Consolidated Leverage Ratio is greater than 3.50, the amount of dividends and other Restricted Payments (as defined in the Amended Credit Agreement) we may pay is limited to an amount up to $50 million.
Borrowings outstanding under the Amended Credit Agreement at June 30, 2026 totaled $834.0 million, consisting of $454.0 million outstanding under the Revolver and $380.0 million outstanding under the Term Loan. Borrowings outstanding under the Amended Credit Agreement at December 31, 2025 totaled $511.0 million, consisting of $121.0 million outstanding under the Revolver and $390.0 million outstanding under the Term Loan. These borrowings carried a weighted average interest rate of 5.3% at both June 30, 2026 and December 31, 2025, including the impact of the interest rate swaps described in Note 10 “Derivative Instruments and Hedging Activity” within the notes to the consolidated financial statements.
The borrowing capacity under the Revolver is reduced by any outstanding borrowings under the Revolver and outstanding letters of credit. At June 30, 2026, we had outstanding letters of credit totaling $0.4 million, which are used as security deposits for our office facilities. As of June 30, 2026, the unused borrowing capacity under the Revolver was $245.6 million.
Refer to Note 8 “Financing Arrangements” within the notes to the consolidated financial statements for additional information on the Amended Credit Agreement.
Future Financing Needs
Our primary financing need is to fund our long-term growth. Our growth strategy is to expand our service offerings, which may require investments in new hires, acquisitions of complementary businesses, possible expansion into other geographic areas, and related capital expenditures.
We believe our internally generated liquidity, together with our available cash and the borrowing capacity available under our senior secured credit facility will be adequate to support our current financing needs and long-term growth strategy. Our ability to secure additional financing in the future, if needed, will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.
OFF-BALANCE SHEET ARRANGEMENTS
We are not a party to any material off-balance sheet arrangements.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). We regularly review our financial reporting and disclosure practices and accounting policies to ensure that our financial reporting and disclosures provide accurate information relative to the current economic and business environment. The preparation of financial statements in conformity with GAAP requires management to make assessments, estimates, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Critical accounting policies and estimates are those policies and estimates that we believe present the most complex or subjective measurements and have the most potential to impact our financial position and operating results. While all decisions regarding accounting policies and estimates are important, we believe that there are five accounting policies and estimates that could be considered critical: revenue recognition, allowances for doubtful accounts and unbilled services, business combinations, carrying values of goodwill and other intangible assets, and accounting for income taxes. For a detailed discussion of these critical accounting policies, see Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to our critical accounting policies during the six months ended June 30, 2026.
NEW ACCOUNTING PRONOUNCEMENTS
See Note 3 “New Accounting Pronouncements” within the notes to the consolidated financial statements for information on new accounting pronouncements.
44

Table of Contents

ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are exposed to market risks primarily from changes in interest rates and foreign currency exchange rates and changes in the market value of our investments. We use certain derivative instruments to hedge a portion of the interest rate and foreign currency exchange rate risks.
Interest Rate Risk
We have exposure to changes in interest rates associated with borrowings under our senior secured credit facility. At our option, these borrowings bear interest at one, three or six month Term SOFR or an alternate base rate, in each case plus the applicable margin. At June 30, 2026, we had borrowings outstanding under our senior secured credit facility totaling $834.0 million that carried a weighted average interest rate of 5.3%, including the impact of the interest rate swaps described below. A hypothetical 100 basis point change in the interest rate would have a $5.8 million effect on our pretax income on an annualized basis, including the effect of the interest rate swaps. At December 31, 2025, we had borrowings outstanding under our senior secured credit facility totaling $511.0 million that carried a weighted average interest rate of 5.3% including the impact of the interest rate swaps described below. A hypothetical 100 basis point change in the interest rate would have had a $2.6 million effect on our pretax income on an annualized basis, including the effect of the interest rate swaps.
We enter into forward interest rate swap agreements to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month Term SOFR and we pay to the counterparty a stated, fixed rate. As of both June 30, 2026 and December 31, 2025, the aggregate notional amount of our forward interest rate swap agreements was $250.0 million. The outstanding interest rate swap agreements as of June 30, 2026 are scheduled to mature on a staggered basis through February 28, 2030.
Foreign Currency Risk
We have exposure to changes in foreign currency exchange rates associated with our operations in India and Canada. We hedge a portion of our cash flow exposure related to our INR-denominated intercompany expenses and our translation risk related to our USD-denominated intercompany receivables in Canada by entering into foreign exchange forward contracts.
Indian Rupee Forward Contracts: As of June 30, 2026 and December 31, 2025, the aggregate notional amounts of these contracts were Indian Rupee (INR) 0.69 billion, or $7.3 million, and Indian Rupee (INR) 1.47 billion, or $16.3 million, respectively, based on the exchange rates in effect as of each period end. The outstanding Indian Rupee forward contracts as of June 30, 2026 are scheduled to mature monthly through April 30, 2027.
Canadian Dollar Forward Contracts: As of June 30, 2026 and December 31, 2025, the notional amount of our outstanding Canadian Dollar forward contracts was $20.0 million and $25.0 million, respectively. The outstanding Canadian Dollar forward contract as of June 30, 2026 is scheduled to settle on September 30, 2026.
We use a sensitivity analysis to determine the effects that market foreign currency exchange rate fluctuations may have on the fair value of our foreign exchange forward contract portfolio. The sensitivity of the portfolio is computed based on the market value of future cash flows as affected by changes in exchange rates. This sensitivity analysis represents the hypothetical changes in value of the derivatives and does not reflect the offsetting gain or loss on the underlying exposure. A hypothetical 100 basis point change in the USD to INR and USD to CAD exchange rates would have an immaterial impact on the fair value of our derivative instruments as of June 30, 2026 and December 31, 2025.
Market Risk
We have a 1.69% convertible debt investment in Shorelight Holdings, LLC, a privately-held company, which we account for as an available-for-sale debt security. As such, the investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. To the extent any change in fair value is the result of a change in credit-related factors, such change is recorded to other income (expense), net in our consolidated statement of operations as a change to the allowance for credit losses. The allowance for credit losses is calculated as the difference between the present value of expected cash flows to be generated from the investment and the cost basis, limited to the difference between the fair value and cost basis. As of June 30, 2026, the fair value of the investment was $33.8 million with a total cost basis of $40.9 million. The fair value of $33.8 million includes a $9.3 million allowance for credit losses. As of December 31, 2025, the fair value of the investment was $34.1 million with a total cost basis of $40.9 million. The fair value of $34.1 million included a $10.4 million allowance for credit losses.
We have an equity investment in a privately-held hospital-at-home company, which we account for as equity securities without a readily determinable fair value using the measurement alternative. As such, the investment is carried at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment. As of June 30, 2026 and December 31, 2025, the carrying value of the investment was $0.1 million and $2.4 million, respectively, with a total cost basis of $5.0 million. In the second quarter of 2026, we recognized a non-cash impairment charge of $2.2 million based on the valuation established in the most recent financing round. In the first quarter of 2025, we recognized a non-cash impairment charge of $4.2 million on our investment based on the valuation anticipated from the hospital-at-home company's merger with a third-party. Upon the completion of the merger in the second quarter of 2025, we recognized an additional $0.8 million non-
45

Table of Contents
cash impairment charge based on the final valuation utilized in the merger. The non-cash impairment charges were recorded to other income (expense), net in our consolidated statement of operations.
Refer to Note 11 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on these investments.
We do not use derivative instruments for trading or other speculative purposes. From time to time, we invest excess cash in short-term marketable securities. These investments principally consist of overnight sweep accounts. Due to the short maturity of these investments, we have concluded that we do not have material market risk exposure. Refer to Note 10 “Derivative Instruments and Hedging Activity” within the notes to our consolidated financial statements for additional information on our derivative instruments.

ITEM 4. | CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures
Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of June 30, 2026. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of June 30, 2026, our disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports we file or submit under the Exchange Act, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended June 30, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II—OTHER INFORMATION

ITEM 1. | LEGAL PROCEEDINGS.

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding or subject to any claim that, in the current opinion of management, could reasonably be expected to have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

ITEM 1A. | RISK FACTORS.

See Part 1, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Form 10-K”), which was filed with the Securities and Exchange Commission on February 24, 2026, for a complete description of the material risks we face. There have been no material changes to the Company’s risk factors since the 2025 Form 10-K.

ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Our Stock Ownership Participation Program and 2012 Omnibus Incentive Plan permit the netting of common stock upon vesting of restricted stock awards to satisfy individual tax withholding requirements. During the quarter ended June 30, 2026, we reacquired 2,289 shares of common stock with a weighted average fair market value of $123.60 as a result of such tax withholdings.
In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. The share repurchase program has been subsequently extended and increased, most recently in the first quarter of 2026. The current authorization extends the share repurchase program through December 31, 2026 with a repurchase amount of $900 million, of which $92.0 million remains available as of June 30, 2026. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements.
46

Table of Contents

Period |  | Total Number of Shares Purchased (1) |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |  | Dollar Value of Shares that may yet be Purchased under the Plans or Programs (2)
April 1, 2026 - April 30, 2026 |  | 203,329 |  |  | $ | 128.13 |  |  | 201,340 |  |  | $ | 118,753,436 |
May 1, 2026 - May 31, 2026 |  | 137,345 |  |  | $ | 124.24 |  |  | 137,234 |  |  | $ | 101,700,723 |
June 1, 2026 - June 30, 2026 |  | 100,071 |  |  | $ | 97.12 |  |  | 99,882 |  |  | $ | 91,998,694 |
Total |  | 440,745 |  |  | $ | 119.88 |  |  | 438,456 |  |  |

(1)The number of shares repurchased included 1,989 shares in April 2026, 111 shares in May 2026, and 189 shares in June 2026 to satisfy employee tax withholding requirements. These shares do not reduce the repurchase authority under the share repurchase program.
(2)As of the end of the period.

ITEM 3. | DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. | MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. | OTHER INFORMATION.

Securities Trading Plans of Directors and Executive Officers
The following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted by our officers and/or directors during the second quarter of 2026, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), referred to as Rule 10b5-1 trading plans.

Name and Title |  | Action |  | Date of Rule 10b5-1 Trading Plan Action |  | Scheduled Expiration Date of Rule 10b5-1 Trading Plan |  | Aggregate Number of Shares to be Sold
Debra Zumwalt - Director |  | Adoption |  | 5/15/2026 |  | 5/14/2027 |  | 1,078

During the second quarter of 2026, none of our officers or directors modified or terminated contracts, instructions or written plans for the sale or purchase of our securities intended to satisfy the affirmative defense condition of Rule 10b5-1(c) or adopted, modified or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).
47

Table of Contents

ITEM 6. | EXHIBITS.

(a) The following exhibits are filed as part of this Quarterly Report on Form 10-Q.

|  |  |  |  |  |  |  | Incorporated by Reference
Exhibit Number |  | Exhibit Description |  | Filed herewith |  | Furnished herewith |  | Form |  | Period Ending |  | Exhibit |  | Filing Date
31.1 |  | Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |  | X |  |  |  |  |  |  |  |  |  |
31.2 |  | Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |  | X |  |  |  |  |  |  |  |  |  |
32.1 |  | Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |  |  |  | X |  |  |  |  |  |  |  |
32.2 |  | Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |  |  |  | X |  |  |  |  |  |  |  |
101.INS |  | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |  | X |  |  |  |  |  |  |  |  |  |
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document |  | X |  |  |  |  |  |  |  |  |  |
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  | X |  |  |  |  |  |  |  |  |  |
101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document |  | X |  |  |  |  |  |  |  |  |  |
101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  | X |  |  |  |  |  |  |  |  |  |
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document |  | X |  |  |  |  |  |  |  |  |  |
104 |  | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |  | X |  |  |  |  |  |  |  |  |  |

48

Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  |  |  | Huron Consulting Group Inc.
|  |  |  | (Registrant)
Date: | July 28, 2026 |  |  | /s/ JOHN D. KELLY
|  |  |  | John D. Kelly
|  |  |  | Executive Vice President, Chief Financial Officer and Treasurer

49